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CHAPTER I 
Introduction 
Overview 
The human genome consists of approximately 20,000 to 25,000 protein-coding 
genes, accounting for less than 5% of the total genes in the genome (1-3). Predominantly 
noncoding, it is now appreciated that a significant portion of the transcriptional regulation 
of protein-coding genes resides within these noncoding segments (3-7). From an 
evolutionary perspective, it is tempting to speculate why these regions were conserved if 
they are devoid of purpose (6, 7). It is known that terminal differentiation of cells is 
dependent upon the coordinate expression of gene networks forming distinct cell lineages 
and compartmentalized systems; however, the role of noncoding regulatory elements as 
well as their transcriptional products governing this process remains elusive particularly as 
it pertains to discovery of new classes of regulatory molecules (8). To uncover the 
mechanisms by which noncoding elements participate in gene regulation, we utilize the 
process of CD4+ T cell polarization as a model system where effector fate is established by 
noncoding regulation of hallmark cytokine genes.  
 
Noncoding Regulation and the Histone Code 
Noncoding regulation of genes includes epigenetic architecture, distal conserved 
elements in the genome, and regulatory RNAs. Arguably, the apical layer of noncoding 
mechanisms governing gene regulation is access control (9). Within the nuclear 
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compartment, genomic DNA is efficiently wrapped around histones creating the compact 
nucleosome promoting further higher order structure (9-12). The octameric core of 
heterodimers of histone H2A, H2B, H3 and H4 proteins have flexible N-terminal amino 
acid strands commonly referred to as “tails” that sustain covalent, yet reversible, post-
translational modifications resulting in the formation of heterochromatin (a compact, 
transcriptionally silent genomic status) or euchromatin (a structured, yet more relaxed state 
permissive of transcription) (Figure 1-1) (9, 10, 12-15). Further, patterns of histone 
modifications correlate with functional regions of gene loci. Histone four acetylation 
(H4Ac) is found across actively transcribed genes while histone three, lysine 27 
trimethylation (H3K27me3) or H3K9 di-or tri-methylation is often associated with 
repression (9, 16-18). H3K4me2 marks correlate with poised or actively transcribed genes 
while H3K4me1 or H3K4me3 marks denote enhancer elements as well as active promoters 
(Figure 1-1B) (9, 13, 17-20). In many cases, hallmark genes of linage-specific networks 
possess bivalent histone modifications particularly in precursor or founders cells; however, 
upon commitment histone marks are restored (9) 
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FIGURE 1-1. Post-translational modification of histone proteins influences gene 
expression (13).  
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Of the histone modifications described, methylation and acetylation remain the 
most understood and often correlate with repression or activation of transcription, 
respectively (9, 21). Not only are these modifications on key lysine residues of the histone 
tails effective with respect to strengthening or weakening the interaction between histone 
proteins and DNA but these “marks” are sustained and recognized by a global class of 
protein “reader” components of histone-modifying complexes, the “writers” and the 
“erasers” (9). The dynamic interactions between histone acetyltransferases (HATs) and 
deacetylases (HDACs) as well as histone methyltransferase (HMTs) and 
demethyltransferases (HDMTs) establish formation of these essential marks (9, 22). The 
H3K27me3 mark is orchestrated by EZH2 methyltransferase complexes commonly 
associated with polycomb group proteins (9, 17). In contrast, H3K4me3 marks are 
established by MLL HMT complexes often guided by members of the Set protein family 
(23). The formation and removal of acetyl groups on histone tails is conducted by an 
entirely separate cohort of proteins conferring specificity by recruitment of various histone-
modifying complexes (9). At one time, it was predicted that histone marks were irreversible 
but it is now appreciated that histone marks are highly dynamic and dependent upon cell-
specific lineages and signals governing enhancement or repression of gene regulation 
fortifying the histone code hypothesis (24, 25).  
Similar to epigenetic modifications of histone proteins, methylation of CpG 
dinucleotides exhibits a second example of epigenetic regulation. DNA Methyltransferase 
(DMNT) enzymes catalyze the methylation mark formation and have been shown to be 
required for widespread silencing of gene loci (26, 27). During cell division, DMNT1 
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maintains the heritable patterns of DNA methylation in daughter cells while DMNT3a and 
3b are considered “de novo” methyltransferase enzymes regulating gene repression (13, 
28). Pertaining to cellular differentiation, precursor cells may exhibit heavy CpG 
methylation on lineage-specific genes until driven by external stimuli (13, 26-28). These 
lineage-specific signals promote removal of these marks on necessary genes pertaining to 
that program while promoting widespread methylation across opposing program-related 
genes.  
 
 
Distal Regulatory Elements 
Distal regulatory elements contribute significantly to productive gene expression 
supporting discrete stages of development. Frequently, distal conserved elements are found 
in close proximity (defined by 50 kilobases up-and downstream from the transcription start 
site of the respective gene); however, this is not a requirement as enhancer elements are 
found upwards of a full megabase pair away as evidenced by the gene encoding Sonic the 
Hedgehog (SHH) (29-31). Moreover, the SHH model in humans establishes an important 
point regarding the magnitude of impact that distal noncoding sequences have on gene 
regulation (29-31). For example, one mutation within this long-range distal enhancer 
results in preaxial polydactyly a developmental phenotype where individuals will develop 
an extra thumb due to overexpressed SHH (29-31). Certainly, SHH-induced preaxial 
polydactyly is not the only case of mutations within distal regulatory elements as it is now 
appreciated that when considering the diverse polymorphisms of the human population, 
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small alterations at given nucleotides across the genome often residing within the 
noncoding regions, have significant implications to human health that will continue to be 
resolved with deeper probing of the genome on an individualized level, namely in the clinic 
(30, 31).  
 By definition, distal regulatory elements demonstrate conservation across species, 
are sensitive to DNase I treatment, bear histone modifications indicative of permissive 
chromatin and are void of CpG dinucleotide methylation (32, 33). Transactivating factors 
recognizing canonical binding sequences within these conserved elements allow for 
regulation of protein-coding genes. Binding of transcription factors to distal sites induces 
recruitment of histone-modifying complexes promoting remodeling of the locus as well as 
recruitment of RNA polymerase favoring transcription. Whereas distance might appear to 
be an obstacle, even within the 50 kilobases up-and downstream of a promoter region, 
studies of the beta-globin and IL-4 loci demonstrate that three-dimensional (3D) 
conformation via intrachromosomal looping brings distal enhancers into close proximity 
to locus control regions and promoters (34-36). In mammals, intrachromosomal looping is 
largely orchestrated by transcription factors such as CCCTC binding factor (CTCF) as well 
as cohesion proteins (36, 37).  These studies demonstrate a role for the spatial and temporal 
regulation of genes, however; in general this process is elusive. 
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Noncoding RNA Regulation 
The ENCyclopedia Of DNA Elements (ENCODE) Consortium demonstrates that 
while proteins may not be encoded within noncoding regions, active transcription occurs 
unanimously genome-wide (1, 2, 4). While significant in number it remains to be 
determined whether the majority of transcripts are biologically active. Regulatory RNA 
species provide a significant proportion of these numerous transcripts (38). Several well-
defined RNA species include those involved in the translation of messenger RNA (mRNA) 
directly via enzymatic mechanisms or indirectly through maintaining levels of various 
RNA species (38). For example, pre-mRNA transcripts are spliced into mature mRNA by 
way of the spliceosome comprised of small nuclear ribonuclear proteins (snRNPs). 
Ribosomal RNA (rRNA) and transfer RNA (tRNA) are directly responsible for mRNA 
translation while small nucleolar RNAs (snoRNA) regulate rRNA and tRNA processing in 
the nucleus (38). While these aforementioned categories contribute to maturation of mRNA 
and subsequent translation, microRNA and small interfering RNA (siRNA) species 
modulate gene expression by directly interacting with mRNA transcripts (39-41). miRNA 
are highly conserved RNA molecules spanning approximately 22 nucleotides in length 
(41). Through complementary base pairing with the 3’ untranslated regions of mRNAs, 
miRNA’s promote mRNA transcript instability inhibiting translation (39-41). siRNAs 
utilize complementary base pairing leading to the destruction of RNA transcripts (39, 40, 
42, 43).  Although these brief points highlight the fundamental aspects to small noncoding 
RNA regulation of genes, new species are continuously reported in the literature (Figure 
1-2). 
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FIGURE 1-2. Noncoding RNA species. 
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Long Noncoding RNAs 
Within the regulatory RNA network, a new species was recently described (5, 44). 
Identified through next generation sequencing of the transcriptome based upon H3K4me3 
promoter marks and H3K36me3 marks through the gene body, thousands of long 
noncoding RNAs (lncRNAs) were found to map across the human and the mouse genome 
(44-45). At present, a universal naming system is lacking therefore lncRNAs may also be 
referred to as large noncoding or long inter-or intragenic noncoding RNAs. To capture all 
species I will refer to the greater population as lncRNAs. LncRNA expression is not 
exclusive to mammals, as transcripts are found in plants as well as fungi (46). Despite the 
infancy of the field, lncRNAs are implicated in nearly all compartmentalized phases of 
cellular life particularly evident in cell lineage commitment.  
Found predominantly within the nuclear compartment, lncRNAs are transcribed 
generally in the antisense direction relative to surrounding protein-coding genes by RNA 
polymerase II and exist as an mRNA-like transcript with multiple exons; however, lack 
protein-coding potential (5, 47). Transcript length is greater than 200 nucleotides, 
substantially longer than other regulatory RNAs (47). Most lncRNAs undergo post-
transcriptional modifications such as splicing, addition of the 5’ cap and 3’ 
polyadenylation; however, the purpose of these modifications are poorly understood for 
these noncoding transcripts (47). LncRNA transcript stability is variable despite exhibiting 
lower transcript expression relative to comparable mRNAs (48). Sequence conservation is 
variable and highly divergent (5). Despite this, most genes encoding lncRNAs are located 
within close proximity to their putative target genes (46, 49, 50). Similar to protein-coding 
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gene loci, these regions are enriched for DNase I hypersensitivity as well as histone 
modifications permissive for transcription (32, 33, 46, 51). While each of the 
aforementioned characteristics do not apply to all known lncRNAs, unequivocally 
lncRNAs participate in the noncoding regulation of genes.  
At present, less than 1% of lncRNAs are functionally described in the literature. 
The majority of known lncRNAs are assigned repressive function of target gene 
transcription while a smaller proportion of lncRNAs are defined as enhancers (44-45, 66, 
135). LncRNAs mediate transcriptional control via RNA-protein interactions with 
components of histone-modifying complexes and/or transcription factors, but may also 
influence target gene transcription via complementary nucleotide base pairing as well as 
serving as precursors for smaller regulatory RNAs (137, 139). As lncRNAs are expressed 
in nearly all developmental systems, effort is needed towards evaluating and assigning 
biological function to these molecules (49, 52).   
From a historical perspective, XIST is the prototypical lncRNA and the first to be 
described within the context of embryogenesis and development. Essential for gene dosage 
in female embryos, XIST is transcribed from and mediates a repressive effect in cis across 
the X chromosome to be inactivated (Xi) through a process known as X chromosome 
inactivation. Interacting with the polycomb repressive complex 2 (PRC2) and the 
transcription factor YYI, XIST “covers” the Xi promoting H3K27me3 covalent histone 
modifications resulting in transcriptional silencing (53-55).  Further, this process is 
facilitated by five additional lncRNAs. For example, XIST transcription is enhanced by 
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Jpx, a trans-activating lncRNA but is also repressed by the anti-sense TSIX lncRNA 
providing a model for regulation of lncRNA genes by fellow lncRNAs (56, 57). Further, 
TSIX is implicated in methylation of CpG dinucleotides during X chromosome inactivation 
to repress the XIST promoter (5).  
Similar to X chromosome inactivation, repressive and enhancer lncRNAs influence 
regulation of HOX genes involved in developmental patterning. HOTAIR is transcribed 
adjacent to the HOXC gene and mediates repression of the HOXD gene by serving as a 
molecular scaffold for PRC2-containing histone-modifying complexes as well as LSD1-
containing H3K4-demethylase complexes but is unique in that it modulates the HOXD 
locus in trans (58-60). The HOTAIR mechanism provides the first evidence that lncRNAs 
are not restricted to neighboring genes for regulation but may mediate effects over great 
distances. Together, XIST and HOTAIR provide a framework by which thousands of 
lncRNAs were shown to associate with PRC2 in embryonic stem cells (61). HOTTIP, a 
cis-acting lncRNA involved in HOX gene regulation, activates the HOXA locus via 
interaction with theMLL1/Set1 HMT complex promoting H3K4me3 epigenetic 
modifications (62). Taken together, X chromosome inactivation and HOX gene regulation 
establishes the foundation upon which epigenetic regulation of genes by lncRNAs is 
modeled.  
In addition to epigenetic modifications, lncRNAs facilitate intrachromosomal 
looping as a mechanism of gene regulation. The H19 transcript promotes spatial 
intrachromosomal rearrangement bringing the maternal enhancer in close proximity to the 
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promoter of the IGF2/H19 gene in cooperation with an SRA lncRNA and p68 (50, 63, 64). 
Additionally, a subclass of cis-acting lncRNA was shown to physically interact with 
“Mediator” to exert long-range enhancement of target AURKA and SNAI1 genes through 
intramolecular interactions fortified by chromatin looping (65).  A similar effect has been 
demonstrated in MCF-7 human breast cancer cells where lncRNA-dependent chromatin 
loops were required for enhancement of transcription (66). These studies offer evidence 
for additional complexity to the accepted understanding of spatial arrangement as it 
pertains to gene regulation.  
LncRNAs may also serve as molecular responders within cell signaling networks 
particularly in response to environmental stress promoting apoptosis. LncRNA-p21 and 
PANDA are located within the CDKN1A locus and are regulated by p53, a potent tumor 
suppressor. LncRNA-p21 negatively regulates pro-apoptotic genes conferring cell cycle 
regulation, whereas PANDA responds to DNA damage by sequestration of the NF-YA 
transcription factor resulting in cell survival (67, 68). NRON functions as a negative 
regulator of NFAT downstream of calcium signaling in activated lymphocytes through 
RNA-protein complex formation, resulting in the sequestration of NFAT in the cytosol 
(69). The LncRNA-LET transcript is suppressed in hepatocellular carcinoma in the presence 
of a hypoxic microenvironment, an obstacle for invasive and metastatic solid tumors (70).   
As expected, lncRNAs are implicated in a host of human diseases affecting millions 
of people worldwide including various cancers, Crohn’s disease, cardiovascular disease 
and neurological conditions to highlight a few. HOTAIR and MALAT-1 are known to be 
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predictive markers as well as oncogenic in cancers of the breasts, lungs, colon, prostate, 
and liver (71, 72). In the case of coronary artery disease leading to heart attack and sudden 
death, genetic risk through single nucleotide polymorphisms identified the myocardial 
infarction associated lncRNA transcript (MIAT) correlating with incidence of disease (73). 
From a neurological disease perspective BACE1-AS, the antisense transcript relative to the 
enzyme responsible for cleavage of the amyloid precursor protein, is elevated in post 
mortem samples from patients with Alzheimer’s disease having implications in the Aβ 
plaque formation (74). Another lncRNA, MNSP1AS correlates strongly in patients 
diagnosed with autism spectrum disorder. Surely as genomic analysis of disease-related 
tissue proceeds, more cases of lncRNA-associated disease relatedness will emerge.  
While significant effort has focused on lncRNA function in embryonic stem cells 
and other developmental processes, the role of lncRNAs in the immune system remains 
largely undefined. A foundational array found over 100 lncRNAs expressed in the discrete 
stages of CD8+ T cell development as well as activation in both humans and mice providing 
strong evidence for lncRNA presence in the immune system (75). Further, a separate study 
reported the induction of 1,500 lncRNAs [500 are annotated] in mouse lung tissue upon 
viral infection with SARS (76). Comparison of influenza virus versus SARS virus infection 
identified 37 differentially expressed lncRNAs indicating a role for lncRNAs in immune 
cells particularly in response to microbial pathogenesis. LncRNA involvement within the 
immune system as it pertains to assignment of biological function is largely unknown and 
establishes an open area of investigation within this thriving field.   
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Effector CD4+ T Helper Cell Polarization  
Originating from the thymus, CD4+ and CD8+ T cells are functionally naïve yet are 
carefully selected to identify antigen-derived peptides in the context of major 
histocompatibility complex (MHC) molecules presented on the surface of antigen 
presenting cells (APC) (77, 78). Circulating through the blood into secondary lymph 
tissues, a naïve CD4+ T cell, for example, is presented its cognate antigen by an activated 
APC and initiates the process of activation and effector lineage commitment (79, 80). T 
helper cell polarization depends on three key signals resulting in the expression of essential 
transcription factors driving hallmark cytokine production: ligation of the T cell receptor 
(TCR) followed by costimulatory surface molecules upon antigen presentation in vivo or 
immobilized anti-CD3 under experimental conditions in vitro, are signals one and two, 
respectively, mediating downstream NFAT signal transduction (13, 81). This initial 
cascade results in upregulation of surface molecules including the high affinity IL2 
receptor (IL2R) as well as cytokine receptors (82). In addition to T cell receptor 
stimulation, cytokine stimulation provides the ultimate signal culminating in execution of 
lineage-specific fates (79, 80). Production of the inflammatory cytokines by effector T 
helper cells promotes the clearance of pathogens and tumors as well as support humoral 
immunity through antibody production by B lymphocytes (B cells) (80). At present, there 
are four well-defined polarization programs based upon the master transcription factors 
governing the production of hallmark cytokines: Th1, Th2, Th17 and T regulatory (Treg) 
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while origins of more recently described populations of CD4+ helper cells such as the Th9 
and Th22 phenotypes are less defined especially in vivo (Figure 1-3) (83-85).  
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FIGURE 1-3. CD4+ T cell effector subsets and hallmark cytokines. 
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The Th1 program is defined by interferon gamma (IFN-γ) production contributing 
to macrophage activation and cell-mediated adaptive immunity (27). Execution of the Th1 
program is driven by the presence of IFN-γ, likely generated by natural killer (NK) or 
natural killer T (NKT) cells as the first responders to pathogen infection in addition to the 
cytokine IL-12 (26, 86, 87). Signal transduction through Stat1 culminates in T-bet 
upregulation and together with Stat4, downstream of the IL-12 receptor, governs the 
stochastic remodeling of the IFNG locus while concurrently repressing the hallmark genes 
of the other lineages (88-95). IFN-γ-producing Th1 cells are integral to the clearance of 
bacterial infections with pathogens such as Listeria monocytogenes responsible for food-
borne illness leading to endocarditis, meningitis and spontaneous abortion (96).  
Alternatively, the Th2 lineage is established by the cytokine IL-4 under in vitro 
culture conditions as the endogenous source of IL-4 in vivo is unknown. Together, Stat6 
and the master Th2 transcription factor GATA-3 culminates in cellular expression of IL-4 
similar to the process described for the Th1 locus (97, 98). In vitro and complementary in 
vivo genetic approaches resulting in the deficiency in either Stat6 or Gata-3 demonstrate 
that both are necessary while GATA-3 alone is sufficient to promote IL-4, IL-5 and IL-13 
expression indicative of Th2 polarization (94, 98). Accumulation of H3K9Ac and H3K4me 
histone marks at these loci are dependent upon GATA-3 (16, 99). Whereas Th2 cells 
contribute to clearance of extracellular pathogen infections, exacerbated Th2 activities 
contribute to allergic responses.  
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While the Th1 and Th2 polarization programs establish one axis of regulation, a 
second axis exists between Th17 and Treg cells, the remaining effector polarization types 
discussed herein. In contrast to the Th1 and Th2 polarization paradigm that is seemingly 
fixed, the Th17 lineage is heterogeneous and dependent upon the concentration of 
polarizing cytokines IL-6 and TGF-β (83, 100). Molecular mechanisms leading to the 
production of hallmark cytokines IL-17A, IL-17F, IL-21 and IL-22 are independent of T-
bet and GATA-3 driven instead by Stat3, RORγT and RORα (85, 94, 100, 101). Arguably 
the least understood with respect to signal transduction and gene expression as compared 
to the other effector subsets, it remains clear that Th17 cells have a definitive role in 
parasitic worm infection, are highly proinflammatory and thus are implicated in 
autoimmunity.  
 T regulatory cells (Tregs) are the remaining subset of classically defined effector 
cells although their status as effectors is often debated (102). This population exhibits 
repressive influence on the greater immune response in efforts to balance the often 
proinflammatory nature of the immune response by preventing exhaustive damage. 
Induced by TGF-β, Tregs are governed by the master transcriptional regulator Foxp3. 
Surface molecule expression such as CTLA-4 as well as secretion of IL-10 family 
cytokines mediates attenuation of immune responses. Similar to Th17 cells, Treg 
populations are thought to be heterogeneous particularly highlighted by a growing body of 
literature uncovering the molecular mechanisms of immunosuppression (77, 102).  
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Interferon Gamma (IFNG) 
 The interferon gamma receptor (IFN-γR) is expressed on all nucleated cells 
reinforcing the potency of this cytokine (103, 104). Mice lacking IFN-γR expression 
demonstrate increased susceptibility to Listeria monocytogenes as well as Mycobacterium 
species and vaccinia viral infection in addition to decreased IgG2a titers supporting an 
essential role for IFN-γ in several key areas of adaptive immunity (35, 77, 96, 104). IFN-γ 
is also implicated in a host of human diseases for example, atherosclerosis. Experimental 
evidence demonstrates a pro-atherogenic influence of IFN-γ on the early stages of foam 
cell formation and plaque development resulting in manifestations of chronic vascular 
inflammation promoting disease (105). Taken together these observations necessitate 
understanding the mechanism of IFNG regulation.  
 In addition to Th1 cells, effector CD8+ T cells, NK and NKT cells also express 
significant levels of IFN-γ; however, there are several distinctions in the cell intrinsic 
mechanisms culminating in IFN-γ expression despite sharing a common hematopoietic 
precursor (106, 107). NK and NKT cells are phenotypically mature upon entry into the 
periphery as defined by rapid expression of IFN-γ within hours of stimulation; meanwhile 
naïve CD8+ and CD4+ T cells require three days of polarization to produce equivalent levels 
(87, 106). Th1 and NK cells both require T-bet while CD8+ T cells utilize an alternative T-
box transcription factor known as eomesodermin (Eomes) for Ifng expression (87, 89, 108). 
Aside from transcription factors, required distal regulatory elements are also varied among 
these cellular lineages. 
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Coordinate Expression of the IFNG Locus 
Productive expression of IFNG within immune cells provides an incredibly useful 
experimental system to investigate mechanisms of noncoding gene regulation in lineage 
commitment and terminal differentiation as all currently appreciated methods are utilized 
to regulate the IFNG gene. 
The IFNG locus, which includes 100 kilobases surrounding the gene, sustains 
progressive epigenetic modifications attributed to the development of primary, effector and 
memory Th1 or Tc1 cells. An activated, yet unpolarized Th0 cell is void of H4Ac marks 
across the Ifng locus (26, 27, 79). The balance of HDACs and HATs recruited to locus 
sustains this effect (27, 109). In the presence of Th1 polarizing cytokines, transcription 
factors such as Stat4, Hlx, Runx3 and T-bet bind across the locus at conserved elements as 
well as at the promoter recruiting HATs and HMTs to sustain marks permissive for 
transcription as this phenomenon of seeding and spreading is compromised in Stat4 or T-
bet deficient animals (95, 110, 111). As Th1 or Tc1 cells transition from primary to 
effector-memory cells, these marks are sustained. Further, NK cells exhibit H4Ac across 
the Ifng locus directly ex vivo without stimulation supporting the connection between H4Ac 
marks and rapid IFN-γ production by effector cells (112).  
In the presence of IL-4, initiation of the Th2 program also induces histone 
modifications across the Ifng gene(26). Whereas permissive marks are sustained in primary 
Th1 cells, lineage commitment of Th2 cells results in H3K27me2/me3 marks inducing 
widespread silencing in a parallel seeding and spreading method governed by Stat6, 
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GATA-3 and HMT complexes containing EZH2 (16, 98).  Additionally, IFN-γ expression 
is regulated by CpG dinucleotide methylation(26). Distal sequences across the Ifng locus 
as well as the first intron of IFNG sustain CpG methylation in undifferentiated cells (13, 
26, 27). Moreover, commitment to the Th2 or Th17 lineage induces a hypermethylation at 
these marks fortifying the repression of the gene while under Th1 conditions these marks 
are largely lost as indicated by the hypomethylation status in effector Th1 as well as NK 
cells (87).  
Understanding how the IFNG locus is regulated by distal noncoding elements of 
the genome, particularly in the context of Th1 cell differentiation, has been an area of active 
investigation. The contribution of distal noncoding sequences, commonly referred to as 
conserved noncoding sequences (CNSs), to IFNG regulation has been thoroughly 
investigated in in vitro reporter assays as well as transgenic mouse model systems whereby 
mice express the human IFNG gene in the context of its endogenous locus (Figure 1-4A) 
(26, 27). For example, mice expressing a bacterial artificial chromosome (BAC) transgene 
containing human IFNG in addition to 8.6 kilobases of surrounding genome lacks Th1-
specific expression of IFNG as Th2 cells also express IFN-γ, however; by increasing the 
breadth of the locus to 190 or even 210 total kilobases, the Th1-specific expression is 
restored (112-114). These observations support an essential role for CNSs in proper 
coordination of lineage-specific gene expression.  
Five defined CNSs: CNS-30, CNS-22, CNS-6, CNS-2 and CNS+18/20 
demonstrate differential requirements in each stage of Th1 cell lineage commitment as well 
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as among IFN-γ-producing cells (Figure 1-4B) (26-28, 86, 113-117). By way of example, 
the CNS-30 site located -30 kilobases upstream of IFNG, is required by primary, effector 
and memory Th1 cells as well as NKT cells (114). Recruitment of Runx3 to the CNS-30 
site during early stages of T cell polarization promotes RNA polymerase II recruitment to 
the IFNG promoter while deletion of the CNS-30 site has no effect on histone marks across 
the IFNG locus (113). Similarly, this site is required by NKT cell production of IFNG but 
is not necessary for NK cells. The CNS-6 site confers epigenetic remodeling in the 
transition between naïve and primary Th1 cells (118). Early downstream of TCR signaling, 
transcription factors such as AP-1 and NFAT are recruited to the CNS-6 site promoting T-
bet binding across the IFNG locus (79). In contrast, the CNS+18/20 site is required by 
memory Th1 responses and NKT interferon production while deletion only slightly impairs 
NK cell IFNG expression but has no effect on developing Th1 primary and effector cell 
populations (114).  CNS+18/20 enhances the activity of CNS-6 in effector Th1 cells.  T-
bet has been shown to associate with CNS-22 which is necessary for primary CD4+ T cells 
as well as CD8+ T cells and NK subsets but not effector stimulated CD4+ T cells (116). 
These studies illuminate several key observations. First, NK cell production of IFN-γ does 
not appear to depend on any one CNS whereas Th1 cells ultimately require CNS-30, CNS-
6 and CNS+18/20 depending on the polarization status (26, 27). Second, CNSs recruit 
essential transcriptional regulatory molecules such as Runx3 and T-bet (26). Lastly, 
differences between cells capable of expressing IFNG arise from the need for various CNSs 
over others demonstrating, at least for IFNG, that these sites are instrumental for lineage-
specific expression of genes.  
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FIGURE 1-4. Analysis of the human IFNG locus and distal conserved noncoding 
sequences.  A, CNSs across the IFNG locus in distance relative to the transcription start 
site, mapped locations of two large deletions generated to identify distal CNSs and 
highlighted region of T-bet-dependent H4Ac marks. B, Requirement of four CNSs 
experimentally assessed in among CD4+, NK and NKT cells.  Modified from (26).  
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RNA Regulation of IFNG 
 Lastly, regulatory RNAs are implicated in attenuation of immune responses 
particularly as it relates to IFNG expression. One miRNA, named miR-125b was recently 
demonstrated to be highly expressed in naïve T cells and was predicted to regulate 72 
mRNA targets including the IFNG transcript (119). Further, miR-125b was demonstrated 
to mediate repression of IFNG reinforcing a naïve CD4+ T cell status as overexpression 
significantly impaired the IFNG levels; however, it was determined that the endogenous 
downregulation of miR-125b was indicative of the transition to a effector-memory T cell 
state. A second miRNA shown to participate in IFNG regulation is miR-29, which 
specifically targets both T-bet and Eomes preventing expression in CD4+ T cells (120). 
 
TMEVPG1  
TMEVPG1 ([Theiler's Murine Encephalitis Virus Possible Gene 1] also referred to 
as NeST [NEttoie Theiler’s Pas Salmonella] or Ifng-As1) is the first described lncRNA of 
the immune system involved in regulating a master cytokine such as IFN-γ. Most inbred 
mouse strains are acutely infected with the murine pathogen Theiler’s virus; however, it 
was observed that the SJL strain relative to the B10.S strain fails to clear the virus after 
intracerebral inoculation, sustains a chronic infection, and succumbs to demyelinating 
disease similar to multiple sclerosis (121, 122). In efforts to determine the cause for 
susceptibility to viral persistence, SJL and B10.S congenic mouse strains were 
systematically analyzed at various loci including but not limited to MHC haplotypes as 
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well as at Ifng (121, 122). These studies identified that the Tmevp3 loci located just adjacent 
to Ifng is a region of susceptibility in the context of the demyelinating disease. 
At the start of the body of work described herein, Tmevpg1 the transcribed product 
of the Tmevp3 locus was implicated to be a repressor of Ifng (121, 122). Predominately 
expressed in the spleen and thymus of C57BL/6 and B10.S mice, detectable Tmevpg1 
transcript levels were elevated in both unstimulated mouse and human immune cells and 
upon stimulation inversely correlated with Ifng expression (121, 122).  
Our work examines the noncoding regulation of Ifng particularly in the context of 
Th1 differentiation, thus I aimed to uncover the functional role of Tmevpg1 in IFN-γ-
producing cells of the adaptive immune system. Chapter II describes Tmevpg1 expression 
as it relates to Th1-selective expression of IFN-γ. Further, as described in Chapter III, I 
establish that together the Tmevpg1 and Ifng genes comprise the Th1 locus maintained by 
T-bet. Lastly, encouraged by my studies of Tmevpg1, in Chapter IV I examined results 
from an RNA-sequencing experiment to assess the possibility that other lncRNAs are 
involved in the process of T helper cell lineage commitment. Together, these findings 
emphasize a crucial role for noncoding regulation of compartmentalized gene networks.  
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CHAPTER II 
Influence of Tmevpg1 on the expression of Ifng by Th1 cells 
 
Overview 
While the majority of the genome is noncoding, the transcriptional control of 
protein-coding genes resides within these noncoding regions. Long noncoding RNAs, a 
transcriptional product of noncoding genomic elements, are found in abundance 
throughout the genome appearing to function as either positive or negative regulators of 
neighboring genes. For example, both TMEVPG1 and its mouse orthologue encode 
lncRNAs and are positioned near the interferon gamma gene. Here we show that 
transcription of both mouse and human TMEVPG1 genes is Th1-selective and dependent 
upon Stat4 and T-bet, transcription factors that drive the Th1 differentiation program. Ifng 
expression is partially restored in Stat4-/-Tbx21-/- cells through co-expression of T-bet and 
Tmevpg1 and Tmevpg1 expression contributes to but is not sufficient to drive Th1-
dependent Ifng expression. Our results suggest that TMEVPG1 belongs to the general class 
of lncRNAs that positively regulate gene transcription.  
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Materials and Methods 
Mice 
BALB/cJ.Stat4-/-Tbx21-/-, DO11.10.Stat4-/-, DO11.10.Tbx21-/- and wildtype mice were 
obtained from Christopher L. Williams in the Boothby laboratory. BALB/cJ mice were 
obtained from the Jackson Laboratory (Bar Harbor, ME). All mice were bred in the 
Vanderbilt University animal facilities. Research using mice complied with all relevant 
institutional and federal guidelines and policies. 
Human and mouse lymphocyte culture conditions 
Healthy human PBMC were isolated by Ficoll–Hypaque density centrifugation (GE 
Healthcare). CD4+ or CD8+ T cells were sorted by positive selection and stimulated with 
immobilized anti-CD3 (OKT3; ATCC, Manassas, VA) and soluble anti-CD28 under Th1 
(IL-12 10 ng/ml) or Th2 (IL-4 10 ng/ml) polarizing conditions for three days followed by 
two days of culture with IL-2. Murine BALB/cJ, BALB/cJ.Stat4-/-Tbx21-/-, DO11.10.Stat4-
/-, DO11.10.Tbx21-/- splenocytes (1x106 cells/ml) were stimulated with immobilized anti-
CD3 (2C11; ATCC, Manassas, VA) or OVA323-339 peptide antigen (10 μg/ml) under Th1 
(10 ng/ml IL-12 and 10 ug/ml anti–IL-4 11B11; ATCC), Th2 (10 ng/ml IL-4 and 10 μg/ml 
anti–IFN-γ, R4-642; ATCC), Th17 (10 ng/ml IL-6, 10 ng/ml IL-23, 1 ng/ml TGFβ and 10 
ug/ml anti-IFN-γ) or Th22 (5 ng/ml IL-1β, 10 ng/ml IL-6 and 5 ng/ml TNF-α) polarizing 
conditions for three days. CD4+ T cells were purified by positive selection (Miltenyi 
Biotec). Human or mouse cells were restimulated to generate effector cells by the addition 
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of 50 ng/ml PMA and 1 μM ionomycin for 6 hours or peptide antigen as described in the 
Results section.  
RNA isolation and quantitative RT-PCR 
Total RNA was isolated with TriReagent (Ambion, Inc.). cDNA was synthesized with the 
SSRIII kit (Invitrogen). Transcript levels were determined by SybrGreen quantitative RT-
PCR (RT-PCR) using the following primer pairs: human TMEVPG1 forward 
5’aaacgctggaggagaagtca 3’ and reverse 5’ttctcctccagcgttttacg 3’ and mouse Tmevpg1 
forward 5’cctgaaaatcaccatgcaca 3’ and reverse 5’gttttcgggatgtcgtcaaa 3’. Human and 
murine message levels are expressed as the ratio to GAPDH (or Gapdh) transcript levels 
calculated directly from the Ct. 
siRNA knockdown 
Silencer® Select siRNA duplexes (Ambion, Inc.) were designed against the 5’ Tmevpg1 
sequence: 
 Sense Strand 5’ 3’ Antisense Strand 3’  5’ 
siRNA 1 GAGAAGAGCCUGAGAGAAATT 
TTCUCUUCUCGGACUCUCU
UU 
siRNA 2 GCAGACUAAACUAGAUAGUTT 
TTCGUCUGAUUUGAUCUAU
CA 
Ifng siRNA siRNA ID: 158238 C        cccccccccccccccccccccccc 
scramble 
siRNA 
CAACUGGGACACAUGUGUU
TT 
TTGUUGACCCUGUGUACAC
AA 
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siRNA duplexes (30 pmoles) were transfected into cells by Amaxa Nucleofection 
according to the manufacturer’s instructions (Lonza). After four hours of recovery cells 
were cultured (5 x 105 cells/ml) under Th1 conditions for three days before restimulation. 
IFN-γ was measured in culture supernatants by ELISA (BD OptEIA).  
Tmevpg1 sequencing and overexpression 
Tmevpg1 cDNA clone AA162222 (Open Biosystems) was sequenced at the Vanderbilt 
Sequencing Facility. Full length Tmevpg1 was cloned into the pcDNA3.1/myc-His A 
overexpression vector (Invitrogen). CMV-Tmevpg1, CMV-Tbx21 or CMV-empty vectors 
were transfected (1 μg/106 cells) into polarized splenocytes using Amaxa Nucleofection 
(Lonzabio). 
Statistical analysis 
Statistical significance was determined by Student’s T test.  
 
Results 
Selective expression of TMEVPG1 and its murine orthologue under Th1 polarizing 
conditions 
 
Utilizing the UCSC genome browser configuration we identified a gene, 
AK124066, also named TMEVPG1, which is predicted to transcribe a spliced, noncoding 
mRNA transcript and is positioned approximately 170 kilobases from the IFNG coding 
region (Figure 2-1). The 33 kilobase long TMEVPG1 gene is comprised of four exons and 
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encodes an mRNA of 1791 base pairs in length. TMEVPG1, similar to IFNG, possesses 
multiple Th1-specific DNase I hypersensitivity sites at its promoter as well as epigenetic 
histone marks, H3K9 acetylation and H3K4 mono- and tri-methylation, that are known to 
be associated with active transcription (52, 99). Both TMEVPG1 and its mouse orthologue 
are located on the opposing strand to IFNG. The transcriptional start site of mouse Tmevpg1 
is positioned 117 kilobases from the Ifng transcriptional start site and is spliced into a 
mature transcript 918 base pairs in length. The promoter region and first intron of Tmevpg1 
also exhibit considerable sequence conservation with human TMEVPG1. These data are 
consistent with the possibility that TMEVPG1 encodes a lncRNA transcript selectively 
expressed in Th1 cells relative to Th2 cells. 
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FIGURE 2-1. Relative genomic position of TMEVPG1 and IFNG on human 
chromosome 12. TMEVPG1 is located 170 kilobases away from the IFNG transcription 
start site. Below are the Th1, Th2 and Th17 DNase I hypersensitivity sites. Arrowheads 
indicate the orientation of transcription. 
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To address this possibility, human CD4+ T cells were stimulated in vitro under Th1 
or Th2 polarizing conditions for three days, followed by two days of additional culture with 
IL-2 before restimulation with PMA and ionomycin. Transcript levels of IFNG, 
TMEVPG1, and GAPDH were determined by RT-PCR. Transcript levels of IFNG and 
TMEVPG1 were substantially greater in Th1 cultures compared to Th2 cultures (Figure 2-
2A and 2-2B). We also determined transcript levels of IFNG and TMEVPG1 in PBMCs 
from healthy human control subjects and compared transcript levels by linear regression. 
We found a positive correlation between IFNG and TMEVPG1 transcript levels relative to 
GAPDH (Figure 2-2C). Taken together these results demonstrate that, like IFNG, 
TMEVPG1 transcript levels are selectively expressed in Th1 cultures relative to Th2 
cultures. The linear regression analysis further indicates a strong association between IFNG 
and TMEVPG1 transcript levels in PBMCs. 
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FIGURE 2-2. TMEVPG1 is selectively expressed in Th1 cells and positively correlates 
with IFNG expression in human PBMCs. A and B, Human CD4+ T cells (n=12) were 
cultured under Th1 or Th2 polarizing conditions for three days.  A, IFNG and B, TMEVPG1 
transcript levels relative to GAPDH were determined by SybrGreen RT-PCR. C, 
Relationship between IFNG and TMEVPG1 transcript levels from whole blood samples 
(PAXgene collection tubes) were determined by linear regression analysis (n=12). Results 
are expressed as the mean ± the standard deviation of three independent experiments. **p 
< 0.01 and ***p < 0.001 
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To assess whether murine Tmevpg1 was also preferentially expressed in polarized 
Th1 cells, we measured Tmevpg1 transcript levels in total splenocytes cultured under Th1 
or Th2 polarizing conditions. RNA was isolated after three days in culture at the peak of 
Ifng expression during primary stimulation. Tmevpg1 and Ifng message levels were 
measured by RT-PCR. Consistent with our results in human lymphocytes, Tmevpg1 
transcript levels were significantly greater in Th1 cells than in Th2 cells (Figure 2-3A). 
Tmevpg1 transcript levels were also analyzed in Th17 and Th22 polarized cells to confirm 
Th1 specificity. We also restimulated Th1 effector cells with PMA and ionomycin and 
followed Tmevpg1 transcript levels over time. IL-2 was added to these cultures to sustain 
viability. Restimulation resulted in a marked increase in Tmevpg1 transcript levels that was 
sustained over several days (Figure 2-3B). In contrast to what we observed in Th1 effector 
cultures, Tmevpg1 transcript levels were undetectable in effector CD8+ T cells polarized 
under Th1 culture conditions, which produced a significant amount of IFN-γ (Figure 2-3C 
and 2-3D). We conclude from these experiments that Th1-selective Tmevpg1 expression is 
conserved between murine and human lymphocytes but is not expressed by CD8+ T cells 
under these culture conditions.  Further, restimulation of Th1 cells results in greater 
Tmevpg1 expression levels than observed in primary Th1 cultures implicating a role for 
Tmevpg1 in effector Th1 cells. 
  
 34 
  
 
FIGURE 2-3. Tmevpg1 is selectively expressed in and positively correlates with IFNG 
expression by mouse Th1 cells. A, Ifng and Tmevpg1 transcript levels relative to Gapdh 
in Th1, Th2, Th17 or Th22 polarized cultures. B, Ifng and Tmevpg1 transcript levels 
relative to Gapdh in CD4+ effector Th1 cells after restimulation with PMA and ionomycin. 
Results are expressed as the mean ± standard deviation of three independent experiments. 
C, Ifng and D, Tmevpg1 transcript levels were measured relative to Gapdh in primary and 
effector CD8+ Tc0, Tc1 and Tc2 polarized cells by RT-PCR. Results are expressed as the 
mean and standard error of the mean of at least three independent experiments. **p < 0.01 
and ***p < 0.001 
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Tmevpg1 is regulated by Th1 transcription factors    
 Th1-selective expression of IFN-γ in our model system is dependent upon the 
transcription factors Stat4 and T-bet. Because Tmevpg1 also displays selective Th1 
expression we determined if Tmevpg1 expression was also dependent upon Stat4 and  
T-bet. To do so, we isolated splenocytes from DO11.10.Stat4-/- and DO11.10.Tbx21 -/-  
(T-bet knockout) transgenic mice and stimulated the cells in vitro with OVA323-339 peptide 
and IL-12. After three days, CD4+ T cells were purified and restimulated with OVA323-339 
peptide for 48 hrs. As expected, Ifng transcript levels were substantially diminished in Th1 
cells in the absence of Stat4 or T-bet compared to the DO11.10 wildtype control mice 
(Figure 2-4A). Tmevpg1 transcript levels were also markedly reduced in T cells deficient 
in either Stat4 or T-bet. Additionally, we examined the expression of Ifng and Tmevpg1 in 
primary as well as effector polarized Stat1-/- cells (Figure 2-4B). Effector T cells exhibited 
significant inhibition in the absence of Stat1-/- whereas little effect was observed for Ifng 
or Tmevpg1. These observations support the dependence of Ifng and Tmevpg1 on Th1-
specific transcription factors.  
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FIGURE 2-4. Tmevpg1 induction is dependent upon Stat1, Stat4 and T-bet 
transcription factors. A, Ifng and Tmevpg1 expression in Th1 cells from DO11.10.Stat4-
/-, DO11.10.Tbx21-/- (T-bet knockout) and wildtype mice relative to Gapdh. Results are 
expressed as the mean ± standard error of the mean. B, Ifng and Tmevpg1 expression in 
Th1 cells from BALB/cJ.Stat1-/- in primary and effector cultures relative to Gapdh. Results 
are expressed as the mean ± standard deviation of replicates. *p > 0.05 and **p > 0.01 
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Influence of Tmevpg1 on Ifng transcription 
LncRNAs cluster into two functionally distinct categories: repressors and 
enhancers of transcription of protein-coding genes. We aimed to determine the function of 
Tmevpg1 in Th1 cells via siRNA-mediated knockdown of Tmevpg1. Nucleofection of 
primary cells with Tmevpg1-specific siRNA duplexes 1 and 2 resulted in a reduction of 
Tmevpg1 (Figure 2-5A) and Ifng (Figure 2-5B) transcript levels relative to the scramble 
siRNA transfected polarized splenocytes. Knockdown of Tmevpg1 by siRNA duplex 1 or 
siRNA duplex 2 resulted in a two-fold or four-fold reduction in detectable IFN-γ protein 
in the culture supernatant, respectively, relative to transfection with a non-specific 
scrambled siRNA (Figure 2-5C). Knockdown with Ifng siRNA resulted in a similar 
decrease in IFN-γ protein concentrations. Nucleofection with both Tmevpg1 siRNA 
duplexes 1 and 2 caused a comparable decrease in Tmevpg1 transcript levels while siRNA 
knockdown of Ifng did not affect transcript levels of Tmevpg1. Our conclusion is that 
Tmevpg1 plays a role in Ifng expression by Th1 cells.   
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FIGURE 2-5. Tmevpg1 knockdown impairs Ifng expression in CD4+ T cells. Tmevpg1-
specific, Ifng-specific or scrambled siRNA duplexes were introduced into Th1 polarized 
CD4+ T cells by nucleofection. A, Tmevpg1, B, Ifng and C, IFN-γ levels (measured by 
ELISA) were determined after restimulation with PMA and ionomycin. Results are 
expressed as the mean ± standard deviation of independent experiments.  
*p > 0.05 and **p > 0.01 
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Based upon the results from the siRNA knockdown experiments, we determined if 
overexpression of Tmevpg1 was sufficient to induce Ifng transcription. Full length 
Tmevpg1 was cloned into a CMV expression plasmid. Total BALB/cJ splenocytes were 
stimulated with anti-CD3 under neutral conditions (Th0) or under Th1 or Th2 polarizing 
conditions for three days. CD4+ T cells were isolated and CMV-Tmevpg1 or CMV-empty 
vectors were then transfected (1 μg of plasmid per 106 cells). After a period of rest, cells 
were restimulated with PMA and ionomycin. Nucleofection of CMV-Tmevpg1 into 
primary Th1 cells resulted in an increased expression of Tmevpg1 compared to the empty 
vector control (Figure 2-6A). Ectopic expression of Tmevpg1 in primary CD4+ T cells 
resulted in no significant increase in IFN-γ protein in Th0, Th1, or Th2 cells relative to 
transfection with an empty vector control (Figure 2-6B). 
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 FIGURE 2-6. Tmevpg1 is necessary but not sufficient for IFN-γ expression by Th1 
cells. CMV-Tmevpg1 or CMV-empty expression plasmids were introduced into polarized 
cultures by nucleofection and cultures were restimulated with PMA and ionomycin. A, 
Tmevpg1 transcript levels are expressed relative to Gapdh. B, IFN-γ levels in Th0, Th1 and 
Th2 polarized cultures were determined by ELISA. Results represent the mean of at least 
three independent experiments.   
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We further examined whether Tmevpg1 was sufficient to restore Ifng transcript 
expression in the absence of Stat4 and T-bet. CMV-Tmevpg1, CMV-Tbx21 or CMV-empty 
vector plasmids were transfected into Th1 polarized BALB/cJ.Stat4-/-Tbx21 -/- splenocytes. 
After a period of rest, cultures were restimulated with PMA and ionomycin. Tmevpg1, 
Tbx21 and Ifng transcript levels were determined by RT-PCR. We observed Tmevpg1 
expression to be restored by ectopic expression of T-bet alone in the BALB/cJ.Stat4-/-
Tbx21 -/- cells (Figure 2-7A). CMV-Tmevpg1 and CMV-Tbx21 co-transfection resulted in 
a substantial increase in Ifng transcript levels relative to transfection of CMV-Tmevpg1 or 
CMV-Tbx21 alone (Figure 2-7C). We conclude from these experiments that 
overexpression of Tmevpg1 in trans alone is not sufficient to induce increased Ifng 
transcription in Th0, Th1, or Th2 cells or in Stat4-/-Tbx21 -/- cells except in the presence of 
T-bet.  
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FIGURE 2-7.  Cooperative action of T-bet and Tmevpg1 restores Ifng expression. 
CMV-Tmevpg1, CMV-Tbx21 and/or CMV-empty vector plasmids were transfected into 
Th1 polarized BALB/cJ.Stat4-/-Tbx21-/- cells. Cells were restimulated with PMA and 
ionomycin. A, Tmevpg1 B, Tbx21 and C, Ifng transcript levels are expressed relative to 
Gapdh.  Results represent the mean of at least three independent experiments. 
  
 43 
Discussion 
 Presently, lncRNAs segregate into two functional categories that either repress or 
enhance the transcription of protein-coding genes. To summarize our results, Tmevpg1 and 
its human orthologue, are expressed selectively in Th1 cells relative to Th2, Th17 and Th22 
cells and expression is dependent upon the Th1 specific transcription factors, Stat4 and T-
bet. Our results also demonstrate that Tmevpg1 influences Ifng transcription in response to 
the Th1 differentiation program. In contrast, ectopic expression of Tmevpg1 does not 
increase Ifng transcript levels in Th0, Th1, or Th2 cells; however, Tmevpg1 is able to 
partially restore Ifng expression when T-bet is also overexpressed. One possible 
interpretation is that Tmevpg1 must be expressed from its endogenous locus, or in cis, to 
stimulate Ifng transcription. A second possible interpretation, which our data favor, is that 
Tmevpg1 must act in concert with T-bet, or other critical trans-activating factors, to 
influence Ifng transcription (Figure 2-8). Other studies of enhancer lncRNAs are consistent 
with our results as these lncRNAs also fail to stimulate transcription of protein-coding 
genes in trans or require additional transactivation factors to drive their transcription.   
 A general emerging model is that cell-type specific transcription factors bind to 
lncRNA promoters to drive their transcription. The lncRNAs bind to ubiquitous proteins 
required to establish the epigenetic code and by mechanisms that are incompletely 
understood direct these proteins to their target protein-coding genes. This model does not 
rule out the possibility that these cell-type specific transcription factors also target protein-
coding genes. Our results demonstrate that one lncRNA, Tmevpg1, contributes to Ifng 
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expression as part of the Th1 differentiation program. We predict that additional lncRNAs 
play critical roles in developmental programs required to establish the different functions 
of the immune system. 
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FIGURE 2-8. Summary of Tmevpg1 mediated effects on Ifng expression. Stat 4 and T-
bet are known transcriptional regulators involved in production of IFN-γ (black arrows). 
Here I demonstrate that both Stat4 and T-bet are necessary for Tmevpg1 expression (white 
arrows). While Tmevpg1 alone is not sufficient to induce T-bet or IFN-γ (arrows with red 
X’s), co-expression of Tmevpg1 and T-bet together is capable to partially restore IFN-γ 
(shown in yellow).   
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CHAPTER III 
 
T-bet regulates the Th1 locus from Ifng through Tmevpg1 
 
Overview 
At the transcriptional level IFNG gene regulation, specifically in CD4+ Th1 cells, 
is dependent upon the transcription factors Stat4 and T-bet for expression. Previously, the 
limits of the mouse Ifng gene mapped to +66 downstream marked by an insulator element 
(CCCTC-binding factor sites or CTCF site) (37). This insulator element is located near 
the mapped 3’ end of the Tmevpg1 gene encoding a Th1-specific lncRNA transcript 
involved in the regulation of Ifng. Whereas substantial interest in lineage-specific gene 
regulation and consequently expression has focused on protein-coding genes, little is 
known about how lncRNA genes are regulated. Here I show that T-bet-dependent 
regulation of the Tmevpg1 gene is due to epigenetic remodeling of the locus in developing 
and effector-like Th1 cells, favoring expression. Further, assessment of surrounding distal 
noncoding sequences identifies four sites capable of enhancer activity which actively 
recruit inducible transcriptional regulators, such as NFκB and Ets-1. These transcription 
factors exhibit T-bet dependent recruitment and are partially involved in Tmevpg1 
expression. These findings expand our current understanding of the governing power of T-
bet across what we now define as the Th1 locus.  
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Materials and Methods 
 
Mice 
BALB/cJ and DO11.10 mice were obtained from The Jackson Laboratory (Bar Harbor, 
ME). All mice were bred in the Vanderbilt University animal facilities. Research using 
mice complied with all relevant institutional and federal guidelines and policies. Human 
IFNG BAC transgenic mice were created on the C57BL/6 genetic background previously 
(114).  
 
Cultures 
Primary BALB/cJ or DO11.10 splenocytes (1 × 106 cells per ml) were stimulated with 
immobilized anti-CD3 (2C11; American Type Culture Collection) or OVA323–339 peptide 
antigen (10 μg/ml; InvivoGen) respectively, under neutral Th0 (10 ug/ml anti– IFN-γ and 
10 μg/ml anti–IL-4), Th1 (10 ug/ml anti–IL-4, 11B11; American Type Culture Collection) 
or Th2 (10 ng/ml IL-4 and 10 ug/ml anti– IFN-γ, R4-642; American Type Culture 
Collection) polarizing conditions for 3 days generating primary cultures. Effector cultures 
were generated by restimulation for an additional 48 hours on immobilized anti-CD3 
coated plates. Jurkat T lymphocytes (American Type Culture Collection) were maintained 
in complete RPMI at a density of 5 x105 cells/ml. CD4+ T cells and NK cells were purified 
by negative magnetic selection (Miltenyi Biotec). 
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RNA isolation and RT-PCR 
Total RNA was isolated with TRI Reagent (Ambion). cDNA was synthesized with the 
SSRIII kit (Invitrogen). Tmevpg1 (Life Technologies TaqMan assay ID: 
Mm01161206_m1) and Ifng (TaqMan, Life Technologies) transcript levels were measured 
by RT-PCR and calculated relative to Gapdh (TaqMan, Life Technologies) by the delta-
delta Ct method.  
 
Chromatin immunoprecipitation (ChIP) 
ChIP procedures were followed as described (114) using the following antibodies: anti-
H4Ac (Millipore), Ets-1 (Santa Cruz), NF-κB p65 (Abcam), and anti-rabbit IgG (Sigma). 
Primers used in amplifying chromatin across the Tmevpg1 locus are listed in 
Supplementary Table 3-1. Conserved sequences for HS sites were amplified by using the 
primers listed in Supplemental Table 3-2.  
 
Cell Transfection and Luciferase Assays 
Human HS elements were amplified with the primers listed in Supplemental Table 3-3 
from Jurkat T cell genomic DNA and cloned into the minimal promoter luciferase 
(pGL4.24; Promega) or the promoter-less luciferase construct (pGL4.10; Promega). Jurkat 
T cells were transfected with the luciferase constructs by the DEAE transfection method 
(123) at 1 ug of plasmid per 106 cells. After overnight recovery, cells were stimulated with 
50 ng/ml PMA and 1 μM ionomycin per for 6 hours before luciferase activity was measured 
with the luciferase activity system (Promega) as described by the manufacturer. Cells were 
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treated with BAY11-7085 NF-κB inhibitor (Sigma) for one hour at 5 uM concentration per 
milliliter of culture. Promoter truncations were generated with the primers listed in 
Supplemental Table 3-4 and cloned into the pGL4.10 construct.    
 
Statistical analysis 
Statistical significance was determined by a Student’s t test. 
 
Results 
IFN-γ producing cells share Tmevpg1 expression 
 Like effector Th1 cells, NK and NKT cells also rapidly express Ifng in response to 
extracellular stimuli (Figure 3-1A). Thus, we asked if NK cells also endogenously express 
Tmevpg1. We found that freshly isolated mouse NK cells without stimulation also express 
high levels of Tmevpg1 that were similar in magnitude to effector Th1 cells (Figure 3-1B).  
In vivo, effector-memory T cells (also referred to as polyclonal memory CD4+ cells) that 
express Ifng accumulate with age. In 4-5 week old mice, only ~5% of T cells are of the 
effector/memory phenotype while in 14-18 week old mice, about 90% of T cells are of the 
effector/memory phenotype (124).  We verified that CD4+ T cells from 14-18 week old 
mice express significantly higher endogenous levels of Ifng than CD4+ T cells from 4-5 
week old mice (Figure 3-1C).  We also found that CD4+ T cells from 14-18 week old mice 
express significantly higher endogenous levels of Tmevpg1 than CD4+ T cells 4-5 week 
old mice (Figure 3-1D). Taken together, from both the NK cell observations and survey of 
Tmevpg1 expression in polyclonal memory cells, we speculate that terminally 
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differentiated populations of primed yet unstimulated effector-like NK and polyclonal 
memory cells are capable of rapid IFN-γ production because of the elevated levels of 
endogenous Tmevpg1 transcripts. 
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FIGURE 3-1. Differential expression of Tmevpg1 in Th1 cells, CD4+ T cells and NK 
cells. A, Ifng and B, Tmevpg1 transcript levels were measured relative to Gapdh in cultured 
Th1 cells (levels shown for reference) and purified NK cells. C, Ifng and D, Tmevpg1 
transcript levels were measured in purified resting CD4+ T cells from young (4-6 weeks 
old) and old (14- 18 weeks old) animals. Results are expressed as the mean ± standard error 
of the mean of at least three independent experiments.  
* p > 0.05 and *** p > 0.001 
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T-bet physically associates and regulates epigenetic modifications at the Tmevpg1 locus  
 Th1 polarization promotes the expression of IFN-γ while suppressing Th2-specific 
genes, a process largely orchestrated by noncoding regulatory elements and transcription 
factor recruitment such as with T-bet (112). Through ChIP analysis, T-bet is found to 
associate with the Ifng promoter as well as numerous sites along the 140 kilobase intergenic 
distance between Ifng and Tmevpg1. Further, T-bet is required for the formation, spreading, 
and maintenance of H4Ac histone modifications in this region, promoting an open 
chromatin conformation favoring transcription (112, 116). As Tmevpg1 expression is also 
dependent upon and induced by T-bet, we investigated T-bet association with the Tmevpg1 
locus.  
Splenic cultures were polarized under Th1 conditions for three days to generate 
primary cultures and for five days with an additional 48 hours of stimulation with 
immobilized anti-CD3 to generate effector Th1 cultures. T-bet binding was assessed within 
+3.0 kilobases upstream relative to the Tmevpg1 transcription start site through  
-160 base pairs downstream by ChIP followed by RT-PCR.  T-bet was found to associate 
with chromatin mapping to the Tmevpg1 locus in primary Th1 cells as well as in effector 
Th1 cells relative to isotype control immunoprecipitations (Figure 3-2A). T-bet was 
similarly found to associate with the Ifng promoter (Figure 3-2B) under both stimulation 
conditions; however, was markedly enriched in effector Th1 cultures. Moreover, the 
majority of T-bet association in the primary Th1 cultures focused within ± 200 base pairs 
of the Tmevpg1 transcriptional start site whereas T-bet association was found to spread for 
upwards of +3.0 kilobases across the locus in effector cultures.  Thus, T-bet binds to the 
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Tmevpg1 promoter in primary Th1 cells and spreads across up to +3 kilobases of the 
Tmevpg1 region as cells further differentiate into effector Th1 cells.   
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FIGURE 3-2. T-bet associates with the Tmevpg1 locus in Th1 primary and effector 
cell cultures. T-bet enrichment across the A, Tmevpg1 locus and at the B, Ifng promoter 
was measure in primary and effector Th1 cultures by ChIP assays followed by RT-PCR. 
Results are expressed as the mean ± standard error of the mean from three independent 
experiments.  
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Given the above results, we next examined T-bet-dependent H4Ac patterns at the 
Tmevpg1 gene, a histone modification associated with permissive transcription and 
formation of H4Ac marks at Ifng and various distal Ifng enhancers is known to be 
dependent, in part upon T-bet. Spleen cell cultures from DO11.10 wildtype or 
DO11.10.Tbx21-/- mice were polarized under Th1 conditions for three days to generate 
primary Th1 cultures and five days with 48 hours additional stimulation with immobilized 
anti-CD3 to generate effector Th1 cultures. H4Ac histone modifications were assessed by 
ChIP spanning +3 kilobases upstream to -165 base pairs downstream of the Tmevpg1 
transcriptional start site. Chromatin was enriched and assayed for abundance of H4Ac 
modifications by RT-PCR relative to immunoprecipitations with an isotype control 
antibody.  In primary Th1 cultures, H4Ac modifications were enriched at genomic regions 
surrounding the Tmevpg1 promoter and these modifications required the presence of T-bet 
(Figure 3-3A).  H4Ac modifications were also enriched in effector Th1 cells and these were 
also dependent upon T-bet (Figure 3-3B).  Further, the level of H4Ac modifications was 
higher in effector Th1 cultures than primary Th1 cultures and H4Ac modifications 
appeared to spread across the ~3 kilobase genomic region. These findings suggest that T-
bet associates with sites along the Tmevpg1 locus and is necessary for the seeding and 
spreading of the H4Ac marks across the Tmevpg1 genomic region. 
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FIGURE 3-3. Seeding and spreading of H4Ac marks across the Tmevpg1 locus is 
dependent upon T-bet in primary and effector Th1 cells. H4Ac measurements were 
assayed by ChIP in A, primary and B, effector Th1 cultures.  Results are expressed as the 
mean fold enrichment over the isotype control immunoprecipitations in three independent 
experiments.  
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TMEVPG1 is surrounded by functional enhancer elements dispensable for IFNG 
 The IFNG locus, including all known cis regulatory elements, was previously 
defined by two insulator sequences located at -63 kilobases and +119 kilobases in humans 
and -70 kilobases to +66 kilobases in mice (37, 125). Studies utilizing a human BAC 
transgenic mouse model where mice express the human IFNG gene in the context of a 190-
210 kilobases human locus demonstrate that 190 kilobases of surrounding noncoding 
elements are required for Th1-selective expression of IFNG whereas a smaller transgene 
derived from a plasmid containing the intact IFNG gene and approximately 3 kilobases of 
upstream and downstream of genomic sequence was unable to repress IFNG expression by 
Th2 cells (114, 126). Such observations indicated that proper regulation of IFNG by 
developing Th1/Th2 cells was dependent on noncoding regions within the locus.  
 We identified five, Th1-specific DNase I hypersensitivity sites (HS) between IFNG 
and TMEVPG1 (Figure 3-4A, adapted from the UCSC Genome Browser) indicating that 
these areas represent accessible, open chromatin. Using an unbiased deletion strategy to 
identify noncoding regions conferring Th1-specific IFNG expression, we examined the 
requirement of two large deletions of the 190 kilobase BAC transgene mapping to the 
region between IFNG and TMEVPG1. CD4+ T cells were purified and cultured under 
neutral (Th0), Th1 and Th2 conditions for five days to generate primary Th1 cells or 
subsequently restimulated for 48 hours with immobilized anti-CD3 to generate Th1 
effector cells. Human IFNG mRNA was measured relative to an endogenous control by 
RT-PCR under both culture conditions. Compared to the full BAC transgene, deletion 1 
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and deletion 2 cultures exhibited equivalent abundance of IFNG message relative to Gapdh 
in Th0, Th1 and Th2 primary and effector cultures (Figure 3-4B and 3-4C) coinciding with 
levels of IFN-γ in the culture supernatants (114). These results support the notion that this 
intergenic region is dispensable for IFNG expression. Therefore, if these HS sites possess 
transcriptional enhancer activity, it is likely that they target Tmevpg1 rather than Ifng.  
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FIGURE 3-4. Enhancers in the intergenic region between IFNG and TMEVPG1 are 
not required for IFNG expression. A, Human Th1 locus on chromosome 12 from the 
UCSC genome browser build. Peaks represent DNase I hypersensitivity in polarized 
human Th1, Th2 and Th17 cultures. Locations of unbiased BAC deletions (deletion 1 and 
deletion 2) used to generate human IFNG transgenic mice are shown in the intergenic 
region. Insulator regions at -66 kilobases and +119 kilobases are shown. Distances for each 
HS site are shown relative to IFNG. B, Human IFNG expression by primary and C, effector 
unpolarized (Th0) Th1 and Th2 murine cells from BAC deletion 1, deletion 2 or the full 
human 190 kilobases BAC transgene. Results are expressed as the mean ± the standard 
deviation of IFNG message expression relative to Gapdh. 
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To explore this hypothesis, we assessed enhancer activity of each HS in the context 
of TMEVPG1. Each HS, numbered one through five, was cloned into the pGL4.24 vector 
construct, containing a minimal promoter followed by the luciferase gene. The constructs 
were transfected into Jurkat T lymphocytes at 1 µg per million cells. After overnight 
recovery, the cells were stimulated with 50 ng/ml PMA and 1 µM ionomycin for six hours 
and were subsequently assayed for luciferase activity. Transfection with HS1-, HS2-, HS3- 
or HS4-pGL4.24 constructs resulted in a significant increase in luciferase activity relative 
to vector alone indicating that these DNA elements possess enhancer activity (Figure 3-
5A). Similar levels of enhancer activity were observed in HS1 and HS3 while HS4 had a 
markedly higher level of enhancer activity relative to vector alone. In contrast, HS5 
exhibited a 10-fold decrease in luciferase activity relative to vector alone (Figure 3-5B). 
These findings indicated that HS1, HS2, HS3 and HS4 were functional enhancer elements 
while HS5 appeared to have suppressive function.  
In addition to having enhancer activity, the HS1 element aligns with the TMEVPG1 
transcriptional start site, thus we also evaluated HS1 for promoter activity. To do so, the 
HS1 sequence was cloned into the pGL4.10 promoter-less vector construct followed by the 
luciferase gene and was subsequently transfected into Jurkat T lymphocytes at 1 ug per 
million cells. After overnight recovery, cells were stimulated with 50 ng/ml PMA and 1 
uM ionomycin for 6 hours and assayed for luciferase activity. A three-fold increase in 
luciferase expression was observed relative the vector control supporting the fact that in 
addition to enhancer activity, HS1 also contains the Tmevpg1 promoter (Figure 3-5C).  
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 The HS1 element contains two distinct peaks of Th1-specific DNase I 
hypersensitivity, either of which could contribute to enhancer as well as promoter activity. 
Therefore, we employed a traditional promoter analysis truncation approach to identify 
regions of HS1 that contributed to the observed promoter activity. The HS1 region was 
divided into four segments, cloned into the pGL4.10 vector construct and assayed for 
promoter activity relative to the full HS1 construct alone (Figure 3-5D). Compared to 
transfection of vector alone, the larger region spanning either 1-515 base pairs or 263-774 
base pairs retained similar promoter activity as HS1; however, deletion of the first 250 base 
pairs in 263-774 base pairs resulted in a marked decrease in luciferase activity. 
Additionally, removal of the middle segment leaving only the 1-270 base pair segment 
resulted in an increase in luciferase activity supporting that this is a region for suppressive 
control.  Further, sequence analysis of the HS1 element identified a TATA sequence motif 
as well as canonical Ets-1 and NF-κB (RelA) transcription factor binding sites (Figure 3-
6E). Ets-1 is a transcription factor predicted to function alongside T-bet in contributing to 
the polarization of CD4+ T cells as mice lacking Ets-1 are impaired in proper Th1 
polarization demonstrating the importance for Ets-1 in this process (127-129). These 
results indicate that TMEVPG1 is surrounded by functional enhancer sequences while HS1 
also possesses promoter activity. 
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FIGURE 3-5. Survey of the human Th1 locus from IFNG to TMEVPG1. A and B, 
Human HS elements were cloned into the pGL4.24-luciferase construct under the control 
of a generic minimal promoter. Constructs were transfected into Jurkat T cells via DEAE 
transfection. Results are sown as the mean ± the standard error of the mean of two 
independent transfections. C, HS1 promoter activity was evaluated by cloning into the 
promoter-less pGL4.10 construct in Jurkat T cells. Results are expressed as the mean of 
three independent transfections ± the standard error of the mean. D, Truncations of the HS1 
promoter to identify regions contributing to promoter activity was evaluated by cloning 
fragments into the pGL4.10 construct in Jurkat T cells. Results are expressed as the mean 
of three independent transfections ± the standard error of the mean. E, HS1 sequence 
analysis identifies binding sites for NF-κB and Ets-1.  
* p > 0.05, ** p > 0.01, *** p > 0.001 and **** p > 0.0001 
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Whereas IFN-γ production by primary and effector Th1 cells is dependent upon T-
bet, it is known that T-bet is dispensable for IFNG expression by memory cells (124).  
Inducible transcription factors such as NF-B, in particular, contribute to the rapid IFN-γ 
response in effector-memory Th1 cells (86). As such, we examined NF-κB and Ets-1 
recruitment to the Tmevpg1 locus. Spleen cell cultures from DO11.10 wildtype mice were 
polarized under Th1 conditions for three days for primary cultures and five days with 48 
hours additional stimulation with immobilized anti-CD3 to generate effector Th1 cultures. 
NF-B and Ets-1 recruitment to Tmevpg1 was assessed by ChIP assay spanning +2.3 
kilobases upstream relative to the Tmevpg1 transcriptional start site to -165 base pairs 
downstream of the Tmevpg1 transcriptional start site. NF-κB recruitment to Tmvepg1 was 
relatively low across the locus particularly in primary Th1 cultures (Figure 3-6A).  
However, a distinctive peak of enrichment was detected at -70 base pairs downstream of 
the Tmevpg1 transcription start site in effector Th1 cultures. Conversely, in these same 
samples, Ets-1 was recruited across the locus in both primary and effector Th1 cultures 
(Figure 3-6B).  Thus, both NF-κB and Ets-1, along with T-bet, are recruited to the Tmevpg1 
locus in Th1 cells. 
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FIGURE 3-6. NF-κB and Ets-1 associate with the Tmevpg1 locus in primary and 
effector Th1 cells. A, NF-κB and B, Ets-1 measurements were assayed by ChIP in primary 
and effector Th1 cultures.  Results are expressed as the mean fold enrichment over the 
isotype control immunoprecipitations ± the standard error of the mean from three 
independent experiments.  
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As both NF-κB and Ets-1 associated with Tmevpg1 genomic promoter/enhancers, 
we examined recruitment of these transcription factors to murine HS enhancer elements 
that were identified by sequence conservation to the above human HS elements (the HS2 
element is not conserved between humans and mice). To address this question, spleen cell 
cultures from DO11.10 wildtype or DO11.10.Tbx21-/- mice were polarized under Th1 
conditions for three days for primary cultures and five days with 48 hours addition 
stimulation with immobilized anti-CD3 to generate effector cultures. We found that NF-
κB and Ets-1 were enriched at these conserved HS regions and recruitment was largely T-
bet dependent (Figure 3-7A and 3-7B).  The magnitude of recruitment to mHS3 and mHS4 
was greater than the recruitment to the Ifng promoter (compare Figure 3-7A & 3-7B to 
Figure 3-7C).  Ets-1 was also recruited to each of the mHS enhancer sequences in effector 
cultures and was found to be largely, but not absolutely dependent upon the presence of T-
bet (Figure 3-7D & Figure 3-7E), similar to the pattern observed for  
NF-κB enrichment. Lastly, Ets-1 associated with the Ifng promoter in a T-bet dependent 
manner in effector cultures (Figure 3-7F).  These results support that T-bet is required, in 
part, for inducible transcription factor Ets-1 and NF-κB recruitment to this intergenic 
enhancer sequences. 
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FIGURE 3-7. NF-κB and Ets-1 are enriched at Tmevpg1 enhancer sequences in a  
T-bet dependent manner. A and B, NF-κB and D and E, Ets-1 transcription factors 
bind to homologous mouse Tmevpg1 enhancer sequences in primary (A and D), effector 
(B and E) cultures and at the Ifng promoter under both culture conditions (C and E) in 
DO11.10 and DO11.10.Tbx21-/- Th1 cells. Cells were assayed by ChIP for transcription 
factor binding after 48 hours of restimulation with immobilized anti-CD3. Enhancer 
primers are designated on the x-axis. Results are expressed as the representative mean 
fold enrichment and error bars represent the standard error of the mean over the isotype 
control for three independent cultures. 
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Additionally, we assessed pharmacological inhibition of NF-κB activation by 
treatment with the extensively utilized I-kappa alpha inhibitor BAY11-7085. The HS1-, 
HS2-, HS3-, HS4- and HS5-pGL4.24 constructs were transfected into Jurkat T 
lymphocytes at 1 µg per million cells (130). After overnight recovery, cells were incubated 
in the presence of the inhibitor for one hour followed by stimulation with 50 ng/ml PMA 
and 1 µM ionomycin for six hours before determining luciferase activity. Relative to 
control cultures, cultures treated with NF-κB inhibitors exhibited a marked decrease in 
activity of each enhancer: HS1-HS4, to varying degrees (Figure 3-8A).  Conversely, 
inhibition of NF-κB activity appeared to reverse the repressor activity of mHS5 (Figure 3-
8B). Further, treatment of effector cultures with BAY11-7085 before restimulation resulted 
in impaired Ifng as well as Tmevpg1 expression relative to control cultures. These results 
support an important role for NF-κB activation and recruitment to HS1-HS5 elements to 
achieve stimulus-dependent transcriptional enhancer activity.     
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FIGURE 3-8. NF-κB inhibition reduces enhancer activity in vitro and Tmevpg1 
expression in effector T cell cultures. NF-κB inhibition by BAY11-7085 in Jurkat T 
cells and mouse effector T cell cultures. A, HS1-HS4-pGL4.24 or B, HS5-pGL4.24 
enhancer constructs. Constructs were transfected into Jurkat T cells via DEAE 
transfection. Cells were incubated one hour in the presence of the inhibitor before 
stimulation with PMA and ionomycin for six hours. Relative luciferase activity was 
assessed. C, Ifng and D, Tmevpg1 expression in effector T cells cultures. Cells were 
incubated one hour in the presence of the inhibitor before restimulation with 
immobilized anti-CD3 for 48 hours. All results in this figure are shown as the mean ± 
the standard error of the mean of two independent transfections. *p > 0.05 
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Discussion 
 Here, we provide evidence to extend the breadth of T-bet positive regulation of the 
Th1 locus from Ifng over 170 kilobases upstream to the gene encoding the Tmevpg1 
lncRNA. In previous studies, we found that Tmevpg1 expression is dependent upon the 
master Th1 transcription factor T-bet, but this effect was poorly understood. To summarize 
our results, we find substantial Tmevpg1 transcript expression by terminally differentiated 
effector-like cells primed to rapidly produce IFN-γ such as NK cells and polyclonal 
memory T cells. T-bet associates with the Tmevpg1 locus promoting H4Ac marks in 
primary and effector Th1 cells. T-bet is required for the formation and maintenance of 
H4Ac marks downstream of Ifng, however, this region is not required for IFNG expression 
(112).  This genomic region between Tmevpg1 and Ifng contains a number of Th1-specific 
DNase 1 HS sites to which the inducible transcription factors, NF-κB and Ets-1 are 
recruited in a T-bet dependent fashion.  Four of these sites possess strong transcriptional 
enhancer activity while the fifth possesses transcriptional repressor activity.  Further, 
pharmacological inhibition of NF-κB reduces enhancer activity of the HS1-HS4 elements 
supporting that enhancement from these sites is mediated, in part, by NF-κB. Taken 
together, our data support a mechanism by which Tmevpg1 is transcriptionally regulated 
by T-bet via epigenetic mechanisms enabling recruitment of inducible transcription factors 
to both the Tmevpg1 promoter and gene body as well as distal transcriptional enhancers 
and repressors (Figure 3-9). Our findings not only provide a detailed description of lncRNA 
gene regulation as part of a developmental program but also contribute to the accepted 
mechanism of regulation of Ifng during Th1 lineage commitment.  
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FIGURE 3-9. T-bet-dependent regulation of the Th1 locus. T-bet is required for the 
initial formation and maintenance of global H4Ac (green boxes) across the Th1 locus 
extending from IFNG through TMEVPG1 during the primary as well as effector 
polarization stages of a naïve CD4+ T cell. The open epigenetic confirmation of the locus 
allows for NF-κB (orange ovals) as well as Ets-1 (purple ovals) to bind to the IFNG and 
TMEVPG1 promoters inducing expression. These factors also bind to surrounding HS 
elements within the intergenic region. IFNG (red arrows) and TMEVPG1 (black arrows) 
demonstrate transcriptional regulation by surrounding genomic elements. 
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Our model is generally consistent with recent studies examining the requirement of 
Tmevpg1 for expression of Ifng in response to infection with Salmonella (131). Here, 
Tmevpg1 expression in CD8+ T cells promotes rapid IFN-γ expression in response to 
Salmonella infection through formation of covalent H3K4me3 marks at the Ifng locus 
correlating with active transcription and rapid expression of IFN-γ by CD8+ T cells (131). 
Moreover, in an in vitro assay, Tmevpg1 physically associates with the WDR5 component 
of the MLL/Set1 histone-modifying complex responsible for producing the H3K4me3 
mark (131). These findings are generally supported by studies examining function of other 
lncRNAs. Whereas repressive lncRNAs mediate epigenetic regulation of genes through 
association with PRC2-containing histone complexes, lncRNAs imposing positive 
regulation on target genes are commonly found to associate with the MLL/Set1 complex 
and associated their proteins. 
Our results described herein, support these findings and establish a role for Tmevpg1 
in the priming of terminally differentiated cells such as effector Th1, NK and polyclonal 
memory cells to rapidly express IFN-γ in response to external stimuli. While initial 
expression of Tmevpg1 is mediated through T-bet as part of the initial stages of the Th1 
polarization program, the inducible burst of Tmevpg1 in effector cells is mediated, in part, 
through inducible transcription factors, such as NF-κB and Ets-1.  
  
 72 
Supplemental 
Primer Name 5’ 3’ sequence 
-165 base pairs 
Fwd ACGCTACATTTTAAGGACATGC 
Rev GCAGAGACACACCAACCAAA 
+100 base pairs 
Fwd TGGTGTGTCTCTGCAAGAATG 
Rev TCTGCTGCCAGGAAGAAAGT 
+200 base pairs 
Fwd AGAAGATGGGCAAGGTGT 
Rev TTCCCTTCACAGGTCTTTC 
+400 base pairs 
Fwd ACTTTGATGGAGGGGTGA 
Rev GGAAGCATGTCCCTATGA 
+680 base pairs 
Fwd CTTATAAGGCACCGTGTTTC 
Rev GATAATCTGGGTTTGACTCC 
+875 base pairs 
Fwd GCAGTAAACACCATCACTCA 
Rev CAGCTACCTCCAACAACTTAC 
+1.4 kilobases 
Fwd ATCCTACCCATCCTTTCAAC 
Rev ATCATGCCTTACCCTCAAC 
+2.0 kilobases 
Fwd CCTGGGGTACCAGAGAATAA 
Rev CCTAGTGCTTTAACCCTTGA 
+2.3 kilobases 
Fwd AGTACTGGGGCTAAAGGTGT 
Rev TTCTTTCAGTGAAGCCTACC 
+3.0 kilobases 
Fwd GAGGTGTTCTCCTGGTTACA 
Rev CAGGTAATAGCTGGATTCGT 
 
SUPPLEMENTAL TABLE 3-1. Primer sequences utilized in ChIP assays. 
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Primer 
Name 5’ 3’ sequence 
mHS1 (1) 
FWD CTAGAATAATTCCACCAAAGCTTAC 
REV GAAGGCTAGAATGAAATGGG 
mHS1 (2) 
FWD GCCTTCCCTTCTCCTGTC 
REV GAGCCTGAGAGAAAAATAACACTT 
mHS4 (1) 
FWD AATTAATGCTGTGCTCATCTG 
REV TATCACCCAGCTTCCACTTC 
mHS6 (1) 
FWD GTATTGTGCAAAATTTTAGGAAC 
REV TATTTATTTCATGCCCCCAA 
mHS6 (2) 
FWD GGGGCATGAAATAAATAATCTT 
REV CATGGTTCCAATTTAATCCC 
mHS8 (1) 
FWD TAGAATAATTCCACCAAAGCTTA 
REV GGAAGGCTAGAATGAAATGG 
mHS8 (4) 
FWD ACCTGTCAAAGTGTGACTTTC 
REV CTCTAGGGTACTTCACAGTCTTAG 
 
SUPPLEMENTAL TABLE 3-2. Primer sequences utilized in ChIP assays in murine 
T cell cultures. 
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Primer Name 5’ 3’ sequence 
Human TMEVPG1 
HS 1 
FWD GGTACCAAAACAGAATTCCCACCGTG 
REV CTCGAGTAGAATAGTTCAATCAAAGCTT 
Human TMEVPG1 
HS 2 
FWD GGTACCTATAAATGAGCATCAGTCCC 
REV CTCGAGTGAATTCACCAGCTG 
Human TMEVPG1 
HS 3 
FWD GGTACCGGGGGAAAAATACTAGTTAT 
REV CTCGAGTACTTCTGTCATTTGCCCAT 
Human TMEVPG1 
HS 4 
FWD GGTACCATAAATGTCTCTATTCTGTA 
REV CTCGAGGGCAATATTTTAGAAATATT 
Human TMEVPG1 
HS 5  
FWD GGTACCTTTCCATGCACAAATTATAG 
REV CTCGAGATTTATCCCTTTAAAACAGC 
 
SUPPLEMENTAL TABLE 3-3. Primer sequences that used to amplify human 
enhancer sequences. Enhancer sequences were cloned in the pGL4.24 construct. Forward 
primers marked with a KPN1 and reverse primers were marked with Xho1 restriction 
enzyme sites on the 5’ end, respectively. 
 75 
Primer 
Name 5’ 3’ sequence 
1-509 
FWD [Kpn1] 
AACCTGGTACCATTAAAAAAACAGAATTCCC 
REV [Xho1] 
 TACGCTCGAGGGTTCTCCTAATTCC 
1-270 
FWD [Kpn1] 
AACCTGGTACCATTAAAAAAACAGAAT 
REV [EcoRV] 
 ATCTCGAGGCAGCTTCCTGTT 
507-777 
FWD [Kpn1] 
 AACCTGGTACCCCAACTGTAAGTG 
REV [EcoRV] 
CGACAAGATATCATTCCCTAGAATAG 
270-509 
FWD [Kpn1] ACATAGGTACCCTGCAATTTCAGGTAG C 
REV [Xho1] AATCTCGAGTTCTCCTAATTCCACCCA 
 
SUPPLEMENTAL TABLE 3-4. Primer sequences to generate minimal promoter 
truncations of the human HS1 element. Enhancer sequences were cloned in the pGL4.10 
construct.  
76 
 
CHAPTER IV 
RNA-sequencing based discovery of lncRNAs in polarizing human T cell cultures 
 
Overview 
 Current estimates enumerate 20,000-25,000 protein-coding genes and 
approximately 10,000 lncRNA-coding genes in the human genome (1, 44, 45). While 
significant in number, the lncRNA studies lack assignment of biologic meaning to most of 
the expressed transcripts. Moreover, these genome-wide surveys rely heavily on 
transformed cell lines possibly excluding entire branches of gene networks involved only 
in distinct processes of lineage commitment, for example, in T helper cell polarization. 
Therefore, we took a more biologically relevant approach to lncRNA discovery within the 
process of human T cell polarization from peripheral blood of a healthy human patient. We 
hypothesize that significant lncRNA populations will be expressed in these differentiating 
cells and variation in transcript expression will be largely dependent upon the program 
initiated: Th1, Th2, or Th17. Previously, lncRNA involvement in the process of lineage 
commitment, particularly within the immune system, was largely unknown. Utilizing the 
stochastic fate decisions within CD4+ T cell polarization, we identified 2,788 lncRNA 
transcripts through a RNA-sequencing analysis of Th1, Th2 and Th17 in vitro polarized 
human PBMCs. Our work with TMEVPG1 discussed in Chapters II and III establishes an 
experimental approach to subsequently identify additional lncRNA transcripts involved in 
execution of polarization programs by naïve helper T cells. This work demonstrates the 
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identification of large lncRNA networks of expression involved in key developmental fate 
decisions of cells such as T helper cell commitment.  
 
Materials and Methods 
Human lymphocyte culture conditions 
Healthy human PBMC were isolated from one volunteers and were stimulated in vitro with 
anti-CD3, 1 x 106 cells/ml, under Th1: IL-12 (5 ng/ml), anti-IL-4 (5 ug/ml) and anti-IL17 
(5 ug/ml), Th2: IL-4 (5 ng/ml) and anti-IFN-γ (5 ug/ml), or Th17: IL-1β (10 ng/ml), IL-6 
(20 ng/ml), IL-23 (20 ng/ml), TGF-β1 (5 ng/ml) and anti-IFN-γ (5 ug/ml), polarizing 
conditions. Cultures were harvested after three days to obtain RNA from primary cultures. 
After five days, cultures were restimulated with anti-CD3 and harvested two days later to 
obtain RNA from effector cultures.  
RNA-sequencing sample preparation  
RNA was isolated from cultures using Tri-Reagent (Sigma). Library preparation was 
performed using the Illumina Tru-Seq RNA kit to generate a polyA-enriched cDNA 
library.  Whole genome RNA sequencing was performed by the Vanderbilt Technologies 
for Advanced Genomics (VANTAGE) core. 50 base pairs paired-end reads were generated 
with an Illumina HiSeq 2500. A quality control step was initially performed on the raw 
data to identify potential outliers before any advanced analysis using tools such as Fastx 
Toolkit and FastQC. The RNA data were aligned with TopHat and gene expression levels 
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were quantified using Cufflinks.  RPKM (reads per kilobase per million reads) based 
approaches (Cuffdiff) were used to detect differentially expressed genes. False discovery 
rate (FDR < 0.05) was used to correct for multiple testing. The UCSC genome browser 
(GRCh37/hg19 build) were used to determine chromosomal locations and for other 
computational purposes as described in the text. 
Results 
T helper cell lineage-specific lncRNA expression 
 Our understanding of lncRNAs within the immune system is limited thus in efforts 
to identify lncRNA expression in primary and effector T helper cell polarization, we 
employed a whole genome RNA-sequencing approach. Chase Spurlock, a trainee in the 
Aune laboratory, initiated these studies under Dr. Aune’s direction. Peripheral blood was 
collected from a healthy patient and the mononuclear cells were purified followed by in 
vitro culture under Th1, Th2 or Th17 polarizing conditions. We assessed expression of 36 
protein-coding genes within the RNA-sequencing analysis as well as through RT-PCR. 
Quantitative transcript determinations were highly correlated across this set of genes that 
exhibit a wide range of expression (quantitative range >104) (Figure 4-1A). Thus, 
quantitation of transcript levels by RNA-sequencing yielded similar results to RT-PCR. 
Approximately 54% of the total estimated protein-coding genes and about 28% of the total 
lncRNA encoding genes were expressed at detectable levels in our PBMC cultures relative 
to the total estimated number of protein and lncRNA encoding genes known (Figure 4-1A). 
Additionally, mean expression levels of all mRNAs identified by the RNA-sequencing 
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analysis were found to be substantially higher than the mean expression levels of all 
lncRNAs (about 3-fold) as were the median levels of mRNAs relative to lncRNAs (Figure 
4-1B). Consistent with findings in other experimental systems, the average expression level 
of lncRNA transcripts is reduced in comparison to levels of mRNAs in PBMC cultures.   
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FIGURE 4-1. Expression levels of mRNAs and lncRNAs. A, Expression correlation of 
36 genes determined by RT-PCR and by RNA-sequencing. R2 was determined by 
Pearson’s linear regression. B, Mean and median transcript levels of all expressed mRNAs 
and all expressed lncRNAs in PBMC cultures were determined by RNA-sequencing. 
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We subsequently evaluated the quality of our cultures through detection of genes 
encoding lineage-specific cytokines and transcriptional regulators. As predicted, IFNG was 
expressed selectively under Th1 polarizing conditions. Similarly, IL4, IL13, and IL5 were 
expressed selectively under Th2 polarizing conditions and IL17A, IL17F and IL10 were 
expressed predominantly under Th17 polarizing conditions (Figure 4-2A). Further, we 
examined profiles of transcriptional regulators of these well-established effector lineages. 
Skewing of effector programs is highly dependent upon JAK/STAT signaling mediators 
downstream of cytokine receptor stimulation for example, STAT1 and STAT4 for the Th1 
program; STAT6 for the Th2 program and STAT3 for the Th17 program (Figure 4-3A). 
Whereas STAT1 and STAT3 expression correlated with Th1 and Th17 programs, 
respectively, STAT4 was expressed in both Th1 and Th2 lineages. Whereas STAT6 is 
associated with the Th2 polarization program, we observed equivalent expression levels 
between all primary and effector cultures. Further, we observed that key transcriptional 
regulators of Th1: TBX21, Th2: GATA3, and Th17: RORC and BATF were substantially 
expressed in the corresponding T helper cell cultures (Figure 4-3B). Taken together, these 
results demonstrate that our culture conditions exhibited successful T helper lineage-
specific expression of transcriptional regulators as well as cytokine genes validating the 
usefulness of this system in the investigation of lncRNAs involved in T helper polarization. 
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FIGURE 4-2. Lineage-specific cytokine gene expression in T helper cells. Lineage-
specific cytokine gene expression in A, Th1 B, Th2 and C, Th17 primary and effector 
cultures. Results are expressed as normalized sequence reads.   
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 Approximately 2,788 lncRNA transcripts were identified through our RNA-
sequencing analysis. To begin to assign meaning to the quantified transcripts, I examined 
ratios of lncRNAs within each subset relative to the other two subsets. In general, we 
observed equivalent numbers of lncRNAs expressed at least two-fold greater relative to the 
other subsets in primary polarized Th1, Th2 and Th17 cells ranging between 277 to 369 
individual transcripts (Supplemental Table 4-1). In contrast, transcript numbers derived 
from Th1 effector cultures exhibited 882 and 868 individual transcripts relative to Th2 and 
to Th17 cultures, respectively. Similar numbers were observed when Th2 or Th17 derived 
lncRNAs were compared to those in Th1 cultures; however, Th2 transcripts were fewer in 
number at 257 relative to Th17 numbers and to a similar extent vice versa between the two 
cultures (Supplemental Table 4-1). We take these observations to mean that lncRNA genes 
are differentially induced in Th1, Th2 and Th17 cells in response to polarization under 
primary or effector stimulation.   
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 FIGURE 4-3. Master transcriptional regulator gene expression determined by RNA-
sequencing. A, Expression of STAT genes and B, genes encoding lineage-specific “master” 
transcription factors in primary and effector polarized Th1, Th2 and Th17 cell cultures. 
Results are expressed as normalized sequence reads.   
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As demonstrated in Chapters II and III, I described a strategy to assign biologic 
function to a Th1-specific lncRNA that fails to be expressed in Th2 as well as in Th17 
cells. Utilizing Tmevpg1 expression and regulation as a guide, I examined the expression 
of lncRNA transcripts expressed in each T cell subset. Consistent with our previous 
findings, TMEVPG1 is selectively expressed in Th1 cells (Figure 4-4A). Similarly, we 
identified two novel lncRNA transcripts AC007278.2 and AC007278.3 that were also 
expressed in a Th1-specific manner. AC007278.3 is expressed in both primary and effector 
Th1 cultures while AC007278.2 is substantially expressed by effector Th1 cultures. Both 
lncRNAs are transcribed from two separate intron regions of the IL18 receptor accessory 
protein (IL18RAP), a gene known to be expressed in Th1 cells and regulated by T-bet 
(132). We further examined 35 additional lncRNAs that demonstrated preferential 
expression relative to Th2 and Th17 primary or effector cells.  
Similarly we discovered GATA3-AS1, found adjacent to the gene encoding the Th2 
master transcription factor GATA-3. My analysis of the GATA3-AS1 transcript indicates 
that it is a 3,035 base pair gene located 1.2 kilobases away from the transcription start site 
of GATA-3. GATA3-AS1 appears in two forms, a 2.2 kilobase long transcript comprised of 
two exons and a second 1.369 kilobase long further spliced transcript consisting of four 
exons (Supplemental Figure 4-1A). Transcription of GATA3-AS1 occurs on the negative 
strand relative to GATA-3 and proceeds in the opposing direction; however, whether 
GATA-3 and GATA3-AS1 share a bidirectional promoter is unknown. Sequence 
conservation is highest among placental mammals. Further, epigenetic marks indicate that 
the region upstream of the putative promoter for GATA3-AS-1 is marked with permissive 
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marks favorable for transcription. DNase I hypersensitivity analysis, through the UCSC 
genome browser build, suggests that this area is also accessible in polarized human CD4+ 
Th1, Th2 and Th17 cells. One novel lncRNA, AC004041.2 is also selectively expressed in 
primary and effector Th2 cultures relative to primary and effector Th1 and Th17 cultures. 
We found 20 additional lncRNAs that were preferentially expressed in primary or effector 
Th2 cells. Lastly, 29 lncRNAs were found to be selectively expressed in primary Th17 
cells including AC004041.2 and RP11-98D18.3.  
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 FIGURE 4-4. T helper program-specific lncRNA expression. LncRNA gene expression 
in A, Th1 B, Th2 and C, Th17 primary and effector stimulated cultures. Results are 
expressed as normalized sequence reads.  
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Identification of co-expressed lncRNAs and mRNAs 
 TMEVPG1 and IFNG are co-expressed under Th1 culture conditions and 
TMEVPG1 is required for IFNG transcription in both tissue culture and infectious models 
(131, 133).  GATA3 and GATA3-AS1 are also co-expressed under Th2 culture conditions 
(Supplemental Figure 4-1B and 4-1C).  For these reasons, we determined the extent to 
which T helper lineage-specific lncRNAs were co-expressed with adjacent protein-coding 
genes in the genome.  We identified adjacent protein-coding genes using the UCSC 
genome browser and used Pearson’s linear regression to quantify co-expression across 
primary and effector Th1, Th2, and Th17 cultures.  This analysis confirmed that TMEVPG1 
and IFNG were co-expressed and that GAT3-AS1 and GATA3 were also co-expressed 
(Supplemental Table 4-2 and Table 4-3).  In addition, we found that the novel lncRNA, 
AC004041.2, was co-expressed with IL4, IL13, and IL5 genes. The lncRNA AC004041.2 
is located within the RAD50 gene but is not co-expressed with RAD50.  Interestingly, the 
genomic position of AC004041.2 aligns precisely with the previously described Th2 locus 
control region required for coordinated expression of IL4, IL13, and IL5 (35).  We also 
found that the lncRNAs, RP11-98D18.3 and AC007182.6, were co-expressed with adjacent 
or nearby RORC and BATF, respectively. In fact, 85% of lncRNAs expressed in a Th1, 
Th2, or Th17 lineage-specific manner were adjacent in the genome to co-expressed protein-
coding genes (Supplementary Tables 4-2, 4-3 and 4-4).  A total of 41% of these lineage-
specific lncRNAs were intragenic or within their co-expressed protein-coding gene.  A 
second feature of this genomic organization was that 38% of lineage-specific lncRNAs 
were localized within clusters of 2 or more co-expressed protein-coding genes 
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(Supplementary Tables 4-2, 4-3 and 4-4).  These results are consistent with the general 
notion that lncRNAs tend to regulate adjacent protein-coding genes and identify co-
expressed protein-coding genes as potential lncRNA targets. 
 We also identified lncRNAs with selectively reduced levels of expression in 
primary and effector Th1, Th2, or Th17 culture conditions relative to the opposing culture 
conditions, respectively.  For example, we identified lncRNAs expressed at low levels in 
Th2 cultures and high levels in Th1 and Th17 cultures (Supplementary table 4-5).  As 
above, we examined expression levels of neighboring protein-coding genes and found that 
co-expressed protein-coding genes were more likely to be intragenic or next to the lncRNA 
in question as opposed to far away from the lncRNA in question.  Like the lncRNAs, the 
co-expressed protein-coding genes were uniformly under-expressed in Th2 cultures 
compared to Th1 and Th17 cultures.  Thus, these data support the possibility that these 
lncRNAs, similar to TMEVPG1, may act as transcriptional enhancers of neighboring 
protein-coding genes. 
To further evaluate these points, we compared distances between lineage-specific 
lncRNAs and co-expressed protein-coding genes as a function of distances in kilobases 
between lineage-specific lncRNAs and adjacent protein-coding genes and as a function of 
adjacent protein-coding genes in the genome.  Both types of comparisons demonstrated 
that the majority of protein-coding genes (85%) that contained a lineage-specific lncRNA 
were co-expressed with the lncRNA (intragenic) (Figure 4-5A & 4-5B).  Approximately 
50% of protein-coding genes within 50 kilobases of a lineage-specific lncRNA or were 
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adjacent to the lineage-specific lncRNA were also co-expressed. This frequency decreased 
further by moving further away from the lineage-specific lncRNA.  Thus, proximity in the 
genome is an important contributor to whether or not protein-coding genes and lncRNAs 
are co-expressed.  We also asked if lncRNA genes localized on the sense or antisense 
strands of co-expressed protein-coding genes.  We found that there was about a 50:50 
distribution between lncRNA genes and co-expressed protein-coding genes transcribed 
from the same DNA strand or transcribed from the opposite DNA strand (Figure 4-5C).  
Thus, transcription from the same DNA strand or from opposite DNA strands was unbiased 
for lncRNA genes and co-expressed protein-coding genes.   
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FIGURE 4-5. Frequency of co-expression between lncRNA genes and neighboring 
protein-coding genes. A, Co-expression of lncRNA and protein-coding genes as a function 
of genomic distance in kilobases. B, Co-expression of lncRNA and protein-coding genes 
as a function of nearby protein-coding genes. C, Percentage of co-expressed lncRNA and 
protein-coding genes as a function of directionality. 
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Discussion 
Previously, lncRNA involvement in the process of lineage commitment, 
particularly within the immune system, was largely unknown. Utilizing the stochastic fate 
decisions within CD4+ T cell polarization, we identified 2,788 lncRNA transcripts through 
a RNA-sequencing analysis of Th1, Th2 and Th17 in vitro polarized human PBMCs. 
Analysis of these transcripts led to several observations. First, each T helper cell program 
induces specific expression of numerous lncRNA transcripts. Whereas our previous work 
established evidence for TMEVPG1, we now identified GATA3-AS1 and RP11-98D18.3 as 
Th2 and Th17-specific lncRNAs, respectively. Second, through linear regression, we 
determined that these lncRNAs correlated strongly with neighboring protein-coding genes. 
Lastly, our analysis of global expression demonstrates a strong correlation for co-
expression and genomic distance as it relates to lncRNA expression.  
In addition to a screen examining lncRNA expression within various stages of 
development as well as activation states of CD8+ T cells, our RNA-sequencing results are 
accompanied by a recent report of greater than 1,500 lncRNA transcripts identified in 42 
subsets of murine CD4+ T cells (75, 134). Consistent with our results, global patterns of 
lncRNA expression were distinct within each polarized T helper cell subset. Additionally, 
this screen identified significant numbers of unique lncRNA transcripts within the Th1 
population relative to Th2 and Th17. Moreover, T-bet was found to associate with the 
Tmevpg1 locus, as our data suggest, as well as 209 addition lncRNA genes supporting that 
master transcriptional regulatory molecules are responsible for not only activation of 
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hallmark cytokines and suppression of alternative lineages but also initiating patterns of 
lncRNA expression. The question remains as to the functional requirement of each 
individual lncRNA and the cooperation of gene as well lncRNA regulatory networks 
culminating in appropriate cell fate decisions. As the lncRNA field is in its infancy, 
involvement of lncRNAs as key regulators in essential cellular decisions will become 
apparent as indicated by our observations.  
 
Supplemental Tables and Figures 
 
Tables 
 
 PRIMARY EFFECTOR 
Relative 
cultures 
Th1 Th2 Th17 Th1 Th2 Th17 
Th1  277 285  882 868 
Th2 323  369 988  257 
Th17 289 277  968 312  
 
SUPPLEMENTAL TABLE 4-1. Differentially expressed lncRNA transcripts among 
T helper cell subsets. The number of transcripts in each row represent the number of 
relative reads from the subset designated in each row (Th1, Th2 or Th17) divided by the 
relative reads from the culture in each vertical column (Th1, Th2 or Th17). Cutoff was 2-
fold higher expression and ratios where comparative column had zero reads were excluded.   
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LncRNA Genomic position 
Protein-
coding R
2  P 
Distance 
away in 
kilobases 
Orientation 
RP11-
430C7.4 
1:204,572,162-
204,585,693 MDM4 0.27 NS intragenic sense 
    LRRN2 0.91 0.003 0.6 antisense 
              
RP3-
340N1.5 
1:20,510,734-
20,522,541 PLA2G5  0.16 NS 99  antisense 
    PLA2G2D 0.1 NS 71 sense 
    PLA2G2F 0.09 NS 45 antisense 
    PLA2G2C 0.81 0.01 7 sense 
    UBXN10 0 NS intragenic antisense 
    VWA5B1 0.47 NS 107 antisense 
              
CHRM3-
AS2  
1:239,870,426-
239,882,419 CHRM3 0.88 0.005 intragenic antisense 
              
RP11-
343J24.1 
1:239,867,192-
239,882,366 CHRM3 0.92 0.003 intragenic antisense 
              
RP11-
288L9.4  
1:27,992,571-
27,998,729  IFI6  0.92 0.003 intragenic antisense 
    AHDC1  0.31 NS 132 antisense 
    FGR  0.12 NS 54 antisense 
    FAM76A  0.03 NS 60 sense 
    STX12 0 NS 107 sense 
              
RP11-
525A16.4 
10:112,257,757-
112,258,300 DUSP5 0.91 0.003 intragenic antisense 
    SMC3 0.06 ns 70 sense 
              
RP11-
9E13.2  
10:70,237,755-
70,240,521 HNRNPH3 0.02 NS 146 antisense 
    RUFY2 0 NS 100 sense 
    DNA2 0 NS 63 sense 
    SLC25A1 0.045 NS 5 sense 
    TET1 0.19 NS 83 sense 
              
RP11-
886D15.2 
11:104,934,071-
104,942,268 CASP1 0.77 0.02 intragenic sense 
    CARD16 0.79 0.02 22 sense 
    CASP4 0.63 0.04 21 sense 
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    CASP5 0.9 0.004 70 sense 
    CARD17 0.93 0.002 29 sense 
              
RP11-
428C19.5  
11:19,321,430-
19,329,905 CSRP3 0.21 NS 118 antisense 
    E2F8 0.04 NS 76 antisense 
    NAV2 0.75 0.03 413 sense 
              
RP11-
326C3.2  
11:287,305-
288,298 PSMD13 0.23 NS 51 sense 
    NLRP6 0.94 0.0013 9 sense 
    ATHL1 0.99 <0.0001 2 sense 
    IFITM2 0.28 NS 25 sense 
    IFITM3 0.34 NS 33 antisense 
              
RP11-
113K21.3  
11:82,817,622-
82,818,003 C11orf82  0 NS 205 antisense 
    RAB30  0.65 0.04 125 sense 
    PCF11 0.47 NS 51 sense 
    ANKRD42 0.13 NS 88 antisense 
    CCDC90B 0.69 0.04 155 sense 
              
RP11-
23J18.1  
12:47,529,545-
47,532,153 AMIGO2 0.32 NS 58 sense 
    PCED1B 0.8 0.01 81 antisense 
              
IFNG-AS1  12:68,383,225-68,415,107  IFNG 0.95 <0.0001 140 antisense 
              
RP11-
275I4.2 
15:38,964,056-
38,970,209 C15orf53 0.06 NS 24 sense 
    RASGRP1 0.92 0.003 184 antisense 
              
AC005838.2  17:15,468,796-15,587,613 FAM18B2 0.09 0.004 142 sense 
    CDRT4 0.08 NS 129 sense 
    TRIM16 0.01 NS intragenic antisense 
    CDRT1 0.78 0.02 0 antisense 
              
TOB1-AS1  17:48,939,583-48,987,593 LUC7L3 0.83 0.01 143 sense 
    TOBI 0.88 0.006 intragenic antisense 
    SPAG9 0.33 SN 169 antisense 
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RNF157-
AS1  
17:74,136,637-
74,150,364 ZACN 0.02 NS 61 sense 
    EXOC7 0 NS 59 antisense 
    UBALD2 0.18 NS 125 sense 
    RNF157 0.93 0.002 intragenic antisense 
              
CTC-
378H22.2  
19:42,656,721-
42,661,675 GRIK5 0.21 NS 131 antisense 
    ZNF574 0.07 NS 76 sense 
    POU2F2 0.78 0.02 intragenic antisense 
    DEDD2 0.6 NS 46  antisense 
    ZNF526 0.04 NS 68 sense 
    GSK3A  0.01 NS 78 antisense 
    ERF 0.09 NS 31 antisense 
              
AC007278.3  2:103,055,173-103,056,935 IL1RL1 0.38 NS 128 sense 
AC007278.2 2:103,050,416-103,051,800 IL18R1 0.6 NS 40 sense 
    IL18RAP 0.95 0.001 intragenic sense 
    SLC9A4 0.04 NS 34 sense 
              
AC009299.2  2:162,079,296-162,111,179 TANK 0.74 0.03 intragenic antisense 
    PSMD14 0.1 NS 85 antisense 
              
AC008063.2  2:162,836,116-162,974,655 SLC4A10 0.99 <0.0001 87 antisense 
    DPP4 0.97 0.0003 intragenic antisense 
    GCG 0.43 NS 163 antisense 
    FAP 0.19 NS 191 sense 
              
AF131217.1 21:29,816,870-30,047,170 N6AMT1 0.48 NS 201 sense 
    LTN1 0 NS 253 sense 
    RWDD2B 0.52 NS 350 sense 
    USP16 0.05 NS 354 antisense 
              
RP11-
377G16.2  
4:81,104,434-
81,111,323 PRDM8 0.92 0.003 intragenic antisense 
    FGF5 0.47 ns 83 antisense 
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CTD-
2313F11.1  
5:54,317,127-
54,319,997  ESM1 0.85 0.008 intragenic sense 
    GZMK 0.99 <0.0001 intragenic antisense 
    GZMA 0.59 NS 81 sense 
    CDC20B 0.05 NS 103 antisense 
              
RP11-
325F22.2  
7:104,581,653-
104,602,781 KMT2E 0.45 ns 73 sense 
              
RP5-
1051J4.4  
7:150,446,824-
150,447,182 GIMAP2 0.39 ns 64 sense 
    GIMAP1 0.39 NS 11 sense 
    GIMAP5 0.8 0.02 6 sense 
    TMEM176B 0.25 NS 42 antisense 
    TMEM176A 0.16 NS 51 sense 
 
SUPPLEMENTAL TABLE 4-2. Th1 related lncRNA genes and neighboring 
protein-coding genes.   
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LncRNA Genomic position 
Protein-
coding R
2  P 
Distance 
away in 
kilobases 
Orientatio
n 
RP11-
261C10.3  
1:243,219,616
-243,265,046 CEP170 0.02 NS 44 sense 
              
RP3-
395M20.8 
1:2,481,359-
2,488,450 PLCH2 0.02 NS 74  antisense 
    PANK4 0 NS 42  antisense 
    HES5 0 NS 21  antisense 
    TNFRSF14 0.85 0.008 6 
 
antisense 
    TTC34 0.66 0.04 91 sense 
              
RP11-
38L15.3  
10:46,951,472
-46,966,835 SYT15 0.93 0.002 2 
 
antisense 
              
RP11-
144G6.12 
10:47,213,346
-47,243,502 ANXA8L1 0.94 0.002 56 sense 
    ANXA8 0.97 0.0005 56, sense sense 
    FAM25C 0.97 0.0004 36, sense sense 
    FAM25B 0.99 <0.0001 36, sense sense 
    AGAP9 0.92 0.002 intragenic sense 
    AGAP10 0.96 0.0007 intragenic sense 
              
RP11-
508M1.3  
10:48,927,373
-48,950,972  PTPN20B 
0.000
4 0.97 100 sense 
    AGAP8 0.99 <0.0001 26 sense 
    BMS1P1 0.92 0.002 intragenic sense 
              
GATA3-
AS1  
10:8,092,413-
8,095,447 TAF3 0.03 NS 35 sense 
    GATA3 0.87 0.007 1 antisense 
              
RP11-
234B24.4 
12:4,809,583-
4,829,268 NDUFA9 0.09 NS 51 sense 
    GALNT8 0.21 NS 20 sense 
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    KCNA6 0.91 0.003 109 sense 
    KCNA1 0.1 NS 110 sense 
              
RP11-
977G19.12  
12:56,702,652
-56,703,233 SMARCC2 0.01 NS 119   
    RNF41 0.87 0.006 87 antisense 
    SLC39A5 0.11 NS 71 sense 
    ANKRD52 0.17 NS 50 antisense 
    COQ10A 0.05 NS 38 sense 
    CS 0.04 NS 23 antisense 
    CNPY2 0.3 NS intragenic antisense 
    PAN2 0.15 NS 8 antisense 
    IL23A 0.14 NS 30 sense 
    STAT2 0.1 NS 40 antisense 
              
RP11-
731F5.1  
14:106,067,80
9-106,071,694 MTA1 0.48 NS 81 antisense 
    CRIP2 0.11 NS 128 sense 
    TMEM121 0.2 NS 75 sense 
    IGHE 0.98 0.0001 intragenic sense 
              
 CTD-
3092A11.2 
15:30,780,166
-30,782,516 
CHRFAM7
A 0.45 NS 127   
    GOLGA8R 0.23 NS 88   
    GOLGA8Q 0.12 NS 64   
              
CTD-
2616J11.3  
19:51,917,552
-51,918,219 IGLON5 0.95 0.001 102 sense 
    VSIG10L 0.95 0.0008 72 antisense 
    ETFB 0.97 0.0004 59 antisense 
    CLDND2 0.67 0.04 45 antisense 
    NKG7 0.11 NS 42 sense 
    LIM2 0.01 NS 34 antisense 
    SIGLEC10 0.98 0.0002 intragenic antisense 
    SIGLEC12 0.68 0.04 77 antisense 
              
AC017074.
2 
2:114,435,279
-114,461,655 DDX11L2 0.35 NS 79 sense 
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    RPL23AP7 0.85 0.009 51 sense 
    RABL2A 0.18 NS 35 antisense 
    SLC35F5 0.24 NS 10 sense 
              
AC105344.
2  
2:231,849,083
-231,860,746 CAB39 0.11 NS 164 sense 
    ITM2C 0.73 0.03 120 sense 
    GPR55  0.96 0.0005 74 antisense 
    SPATA3 0.31 NS 11 antisense 
    PSMD1 0.26 NS 72 antisense 
    HTR2B 0.8 0.02 123 sense 
              
DGUOK-
AS1  
2:74,174,769-
74,208,568  STAMBP  0.38 NS 49 sense 
    DGUOK  0.91 0.003 intragenic antisense 
    TET3 0.22 NS 99 antisense 
              
AC004041.
2  
5:131,966,281
-131,977,465 IRF1 0.13 NS 149 sense 
    IL5 0.89 0.004 89 sense 
    RAD50 0.54 NS intragenic antisense 
    IL13 0.9 0.004 27 antisense 
    IL4 0.83 0.008 13 antisense 
    KIF3A 0.25 NS 32 sense 
    CCNI2 0.24 NS 117 antisense 
              
RP11-
305L7.1 
9:93,867,239-
93,869,586 AUH 0.85 0.009 9 sense 
              
RP11-
305L7.3 
9:93,881,420-
93,925,369 AUH 0.87 0.006 200 sense 
 
SUPPLEMENTAL TABLE 4-3. Th2 related lncRNA genes and neighboring 
protein-coding genes.  
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LncRNA Genomic position 
Protein-
coding R
2  P 
Distance 
away in 
kilobases 
Orientation 
RP11-
126K1.6 
1:151,319,443-
151,320,503 VPS72  0.53 NS 171 sense 
    PIP5K1A  0.07 NS 148 antisense 
    PSMD4  0 NS 80 antisense 
    ZNF687  0.01 NS 55 antisense 
    PI4KB  0.39 NS 19 sense 
    RFX5  0.7 0.03 intragenic antisense 
    PSMB4  0.01 NS 53 antisense 
    POGZ 0.25 NS 56 sense 
              
RP11-
98D18.3 
1:151,735,860-
151,741,977 SNX27  0.97 0.0003 64 antisense 
    OAZ3  0.26 NS intragenic sense 
    TDRKH  0.95 0.001 11 sense 
    LINGO4  0.73 0.03 37 sense 
    RORC  0.8 0.02 41 sense 
    C2CD4D 0.84 0.001 75 sense 
    THEM4  0.41 NS 108 sense 
              
AL450992.2 1:151,814,353-151,822,861 SNX27  0.9 0.004 143 sense 
    OAZ3  0.12 NS 71 sense 
    TDRKH  0.84 0.01 51 antisense 
    LINGO4  0.97 0.0004 37 antisense 
    RORC  0.98 0.0002 10 antisense 
    C2CD4D 0.99 <0.00001 1 antisense 
    THEM4  0.1 NS  intragenic antisense 
              
RP5-
997D24.3  
1:54,751,078-
54,753,044 CDCP2  0.12 NS 147 antisense 
    CYB5RL  0.33 NS 113 antisense 
    MRPL37  0.4 NS 86 sense 
    SSBP3 0.36 NS intragenic antisense 
              
RP11-
783K16.5 
11:64,013,436-
64,015,689  VEGFB  0.49 NS 11 sense 
    FKBP2  0.09 NS 2 sense 
    PPP1R14B  0.55 NS intragenic antisense 
    PLCB3 0.6 NS 3 sense 
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RP11-
290L1.3 
12:76,424,274-
76,425,158 PHLDA1  0.97 0.0002 intragenic antisense 
    NAP1L1 0.68 0.04 14 antisense 
              
AL928768.3 14:106,170,301-106,170,939 IGHE 0.17 NS intragenic antisense 
    IGHG4 0.83 0.01 3 sense 
    IGHG2 0.89 0.005 59 sense 
    IGHA1 0.85 0.009 3 sense 
    IGHG1 0.88 0.006 32 sense 
    IGHG3 0.82 0.01 65 sense 
              
AC007182.6 14:76,041,231-76,045,931 BATF  0.78 0.02 28 antisense 
    C14orf1 0.04 NS 76 sense 
    TTLL5 0.48 NS 81 sense 
              
RP11-
488C13.5 
14:77,248,083-
77,253,067  VASH1  0.99 <0.0001 intragenic antisense 
    ANGEL1  0.45 NS 1 sense 
              
CTD-
2008A1.1 
15:45,118,738-
45,119,292 PATL2  0.43 NS 161 antisense 
    B2M  0.18 NS 108 sense 
    TRIM69 0.43 NS 58 sense 
              
GAPB1-
AS1 
15:50,647,664-
50,650,501  SLC27A2  0.06 NS 119 sense 
    HDC  0.2 NS 89 antisense 
    GABPB1  0.13 NS 1 antisense 
    USP8 0.04 NS 69 sense 
              
RP11-
876N24.5 
16:11,032,743-
11,033,901  NUBP1  0.38 NS 169 sense 
    TVP23A  0.76 0.02 120 antisense 
    CIITA  0.72 0.03 14 sense 
    DEXI  0.67 0.04 intragenic antisense 
    CLEC16A 0.05 NS 6 sense 
              
RP11-
304L19.3 
16:2,144,831-
2,147,027 GFER  0.12 NS 110 antisense 
    SYNGR3  0.57 NS 105 antisense 
    ZNF598  0.19 NS 97 sense 
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    NPW  0.54 NS 75 antisense 
    SLC9A3R2  0.83 0.01 55 antisense 
    TSC2  0.11 NS 6 antisense 
    PKD1  0.28 NS intragenic sense 
    RAB26  0.67 0.04 51 antisense 
    TRAF7  0.01 NS 58 antisense 
    CASKIN1  0.04 NS 83 sense 
    MLST8 0.17 NS 111 antisense 
              
AC002331.1 16:26,596,075-26,606,134  none         
              
IL21R-AS1 16:27,458,991-27,464,714  IL4R  0.25 NS 82 antisense 
    IL21R  0.99 <0.0001 intragenic antisense 
    GTF3C1 0.39 NS 13 sense 
              
AC074212.5 19:46,268,042-46,272,311 GIPR  0.04 NS 83 sense 
    QPCTL  0.14 NS 73 sense 
    FBXO46  0.03 NS 34 antisense 
    SIX5  0.72 0.03 intragenic antisense 
    DMPK  0.62 0.04 1 antisense 
    DMWD  0.63 0.04 14 antisense 
    SYMPK 0 NS 46 antisense 
              
AC096579.7 2:89,156,709-89,165,653 IGKC  0.99 <0.0001 intragenic antisense 
    IGKV4-1  0.99 <0.0001 19 antisense 
    IGKV5-2  0.99 <0.0001 31 antisense 
    IGKV6-21  0.89 0.005 294 sense 
    IGKV2-40  0.85 0.009 473 sense 
    IGKV2D-26  0.99 <0.0001 859 antisense 
    IGKV3D-20  0.99 <0.0001 912 antisense 
    IGKV1D-13  0.98 0.0002 1027 antisense 
    IGKV3D-11 0.98 0.0001 1046 antisense 
              
LINC00176 20:62,665,697-62,671,315 DNAJC5  0.23 NS 98 sense 
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    UCKL1  0 NS 78 antisense 
    ZNF512B  0.56 NS intragenic antisense 
    SAMD10  0.69 0.04 55 antisense 
    PRPF6  0.14 NS 53 sense 
    SOX18  0.4 NS 1 antisense 
    TCEA2  0.13 NS 23 sense 
    OPRL1  0.85 0.01 45 antisense 
              
RP11-
398A8.3 
3:72,084,451-
72,149,578 EIF4E3  0.69 0.04 310 sense 
    GPR27  0.49 NS 280 antisense 
    PROK2  0.09 NS 250 sense 
    RYBP 0.7 0.04 274 sense 
              
RP11-
213H15.3 
5:90,606,838-
90,610,219 GPR98  0.26 NS 146 antisense 
    ARRDC3 0.16 NS 58 sense 
 
SUPPLMENTAL TABLE 4-4. Th17 related lncRNA genes and neighboring 
protein-coding genes.  
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 LncRNA Genomic position 
Protein-
coding R
2  P Distance away in kilobases Orientation 
RP11-
87G24.6 
 17:74,953,105-
74,954,304  MGAT5B 0.91 0.003 10 antisense 
              
RP11-
445P17.8 
10:5,307,996-
5,313,199  AKR1CL1 0.49 NS 80 sense 
              
CTB-
58E17.9 
17:36,871,581-
36,876,525 CWC25 0.35 NS 102 sense 
    PIP4K2B  0.15 NS 61 sense 
    PSMB3  0.24 NS 38 antisense 
    C17orf96  0.02 NS 44 sense 
    MLLT6  0.76 0.02 intragenic antisense 
    CISD3  0.17 NS 15 antisense 
    PCGF2 0.02 NS 19 sense 
              
RP11-
15A1.3  
19:44,395,956-
44,405,955 ZNF283  0.57 NS 42 sense 
    ZNF221  0.31 NS 50 antisense 
    ZNF45  0.89 0.004 11 sense 
    ZNF404 0.16 NS 14 sense 
              
RP11-
714G18.1 
4:186,291,879-
186,312,082 SNX25  0.86 0.008 intragenic sense 
    LRP2BP  0.81 0.009 intragenic antisense 
    ANKRD37  0.06 NS 5 antisense 
    UFSP2  0 NS 8 antisense 
    C4orf47  0 NS 38 sense 
    CCDC110 0.03 NS 54 antisense 
              
RP5-
1028K7.2 
17:38,673,278-
38,683,254  RARA 0.07 NS 150 sense 
    TOP2A  0.2 NS 99 antisense 
    IGFBP4  0.77 0.02 60 sense 
    TNS4  0.2 NS 16 antisense 
    CCR7  0.18 NS 27 antisense 
    SMARCE1 0.43 NS 100 antisense 
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CTD-
3094K11.1 
15:91,382,954-
91,384,608 BLM 0.03 NS 122 sense 
    FURIN  0.72 0.03 27 sense 
    MAN2A2  0.92 0.003 63 antisense 
    FES  0.7 0.04 43 sense 
    UNC45A  0.24 NS 94 sense 
    HDDC3  0.01 NS 92 antisense 
    RCCD1 0.42 NS 114 sense 
              
RP11-
689B22.2 
12:109,022,463-
109,035,094 SART3 0.09 NS 67 antisense 
    ISCU  0.29 NS 59 sense 
    TMEM119  0.69 0.03 31 antisense 
    SELPLG  0.66 0.04 intragenic antisense 
    CORO1C 0.09 NS 3 antisense 
              
RP11-
254F7.2  
2:10,179,219-
10,180,790 TAF1B 0.55 NS 5 antisense 
    GRHL1  0.1 NS 37 antisense 
    KLF11  0.69 0.04 intragenic antisense 
    CYS1  0.02 NS 16 sense 
    RRM2  0.51 NS 82 antisense 
    C2orf48 0.01 NS 101 antisense 
              
RP11-
126O1.5 
18:56,337,712-
56,339,109 ALPK2  0.97 0.0003 41 sense 
    MALT1 0.85 0.009 intragenic antisense 
              
AC069363.1  17:34,400,226-34,417,203 CCL3  0.85 0.009 intragenic antisense 
    CCL4  0.96 0.0006 14 sense 
    TBC1D3B  0.02 NS 77 antisense 
    CCL3L1  0.8 0.01 105 antisense 
    CCL3L3  0.73 0.03 105 antisense 
    CCL4L2 0.98 0.0001 121 sense 
              
RP11-
252E2.1 
16:75,142,499-
75,144,610 ZNRF1 0.98 <0.0001 intragenic antisense 
    LDHD  0.55 NS 2 sense 
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    ZFP1 0.55 NS 38 antisense 
    CTRB2 0.16 NS 93 sense 
 
SUPPLEMENTAL TABLE 4-5. Th2 down regulated genes lncRNA genes. 
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Figures 
 
 
SUPPLEMENTAL FIGURE 4-1. GATA3-AS1 demonstrates Th2-specific expression. 
A, GATA3 locus from the UCSC genome browser configuration. GATA3 gene and GATA3-
AS1 mapped transcripts are shown. DNase I hypersensitivity peaks are shown for human 
Th1, Th2 and Th17 polarized subsets. B, IFNG and C, IL-4 measurements were normalized 
relative to GAPDH in primary Th1, Th2 or Th17 conditions.  
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CHAPTER V 
DISCUSSION 
 
 Herein, I describe my work evaluating the function and biology of the lncRNA, 
Tmevpg1 within the context of the Th1 polarization program namely as an enhancer of Ifng 
transcription. In chapter II, I evaluated Tmevpg1 expression by CD4+ and CD8+ T cells, the 
major subsets of IFN-γ-producing immune cells, upon various stimulation conditions 
finding that expression was exclusive to polarized CD4+ Th1 cells. Tmevpg1 levels 
correlate strongly with Ifng transcript levels and induction of both Tmevpg1 and Ifng 
transcription in response to Th1 polarization display similar dependence upon Stat4 and T-
bet transcription factors. The most significant finding in this work is the discovery that 
Tmevpg1 is necessary for efficient Ifng expression, an observation that has not been made 
within the immune system particularly in the context of genes that encode cytokines. A 
second significant conclusion is that both T-bet and Tmevpg1 cooperate to induce the high 
levels of Ifng transcripts that define the effector Th1 cell lineage.  These studies also 
demonstrate that Tmevpg1 is capable of functioning as an RNA molecule in trans. As 
lncRNAs may function either in cis or in trans to regulate gene expression as diffusible 
molecules, our evidence suggests that Tmevpg1 is a cis-acting lncRNA regulating the Ifng 
locus just adjacent to the Tmevpg1 locus.  
Shortly after publishing Chapter II in manuscript form, a follow-up report 
confirming the role of Tmevpg1 as an enhancer lncRNA capable of regulating expression 
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of the Ifng gene was published by Gomez et. al. out of Stanford University (131). In this 
report, transgenic overexpression of Tmevpg1 in CD8+ T cells results in rapid IFN-γ 
responses elicited in response to Salmonella pathogenesis highlighting a critical role for 
this lncRNA in protection against bacterial pathogenesis (131). Moreover, transgenic 
overexpression of Tmevpg1 resulted in increased expression of TNF-α, RANTES, and IL-
2 in addition to IFN-γ (131). Within this study, a mechanism was proposed for Tmevpg1 
enhancement of Ifng transcription. Similar to other described enhancer lncRNAs, it is 
hypothesized that Tmevpg1 interacts with WDR5 to recruit the histone methylase complex 
MLL/Set1 to the Ifng locus leading to accumulation of H3K4me3 epigenetic marks across 
the locus (135).  Taken together, my results as well as those presented in this subsequent 
publication establishes Tmevpg1 as an enhancer lncRNA contributing to epigenetic 
remodeling of the Ifng locus in cis to promote expression of IFN-γ.  Second, Tmevpg1 plays 
a critical role controlling bacterial pathogenesis, in vivo, by inducing expression of high 
levels of IFN-γ. 
One outstanding question of significant interest to the lncRNA field involves the 
nature of lncRNA gene regulation, as the lncRNA community has focused effort on 
identification of new lncRNAs and their functions.  As our expertise, historically, includes 
analysis of regulation of Ifng transcription by distal noncoding elements and analysis of 
epigenetic remodeling, I began to pose similar questions by extending these methods to 
 111 
explore functions of distal noncoding elements and epigenetic remodeling to better 
understand regulation of the adjacent Tmevpg1 gene.  
As Tmevpg1 expression is dependent upon Th1 transcriptional regulators, is located 
adjacent to Ifng and is highly expressed in effector Th1 cells, I hypothesized that Ifng and 
Tmevpg1 share mechanisms of gene regulation. In Chapter III, I examined the epigenetic 
influence of T-bet demonstrating that establishment and spreading of the positive histone 
mark H4Ac at the Tmevpg1 promoter is dependent upon T-bet. This key observation places 
T-bet in control of epigenetic remodeling between the Ifng and Tmevpg1 genes but also at 
the Tmevpg1 transcriptional start site as well as +3.0 kilobases upstream of Tmevpg1. The 
absence of Tmevpg1 expression in Tbx21-/- cultures therefore is due, at least in part, to 
epigenetic restriction, a feature that had not been previously demonstrated for lineage-
specific lncRNA expression. As Tmevpg1 is expressed at high levels in effector Th1 cells, 
I also examined NK and polyclonal memory T cell populations, which are also capable of 
rapid production of IFN-γ. Equivalent levels of Ifng message and the Tmevpg1 transcript 
are observed in unstimulated NK cells as well as stimulated polyclonal T cell memory 
populations as compared to those levels expressed by cultured effector Th1 cells supporting 
the view that Tmevpg1 function may be important for rapid IFN-γ responses by effector-
like and memory immune cells. 
Within the intergenic distance between the IFNG and TMEVPG1 genes resides five 
distal noncoding elements previously shown be nonessential for IFNG expression in Th1 
cells (Figure 3-4) (114, 115, 136). As these experiments utilized BAC transgenic mice that 
did not include the TMEVPG1 locus, I began to assess these genomic elements for enhancer 
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activity. While four elements demonstrate clear enhancer activity, one was observed to be 
a repressive element supporting that the Tmevpg1 gene is surrounded by elements capable 
of producing dynamic transcriptional regulation. The aforementioned enhancer elements 
are also sites for transcription factor recruitment. NF-κB and Ets-1 associate at varying 
levels in effector Th1 cells to these enhancer elements demonstrating that transcriptional 
regulation of Tmevpg1 may be induced by these factors within effector Th1 cells. 
The degree to which T-bet is capable of regulating Tmevpg1 is significant as I’ve 
shown that T-bet is required for expression, epigenetic remodeling and physically 
associates with the Tmevpg1 locus. Data from Chapter II suggest that T-bet and Tmevpg1 
cooperate to induce Ifng expression but the role of T-bet in facilitating Tmevpg1 
enhancement of Ifng is not well understood. For instance, does Tmevpg1 localize to the 
Ifng locus?  
Previously, it was observed that intrachromosomal looping events across the Ifng 
locus occurred in Th1 cells to promote Ifng expression in a T-bet-dependent manner (36, 
37). Within this work, the transcription factor CTCF was demonstrated to bind to a 
conserved site +66 kilobases 3’ of Ifng and was proposed to establish a boundary for the 
locus (37). This binding allows for intrachromosomal rearrangement bringing distal CNS 
elements into close proximity of the Ifng promoter. These observations in light of my work 
are important for two reasons. First, the spatial rearrangement described within the 
aforementioned body of work is dependent upon T-bet at and spans the Ifng locus (137). 
These findings are consistent with my observation that T-bet regulates the entirety of the 
Th1 locus. Secondly, the CTCF binding insulator element aligns with the 3’ end of the 
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Tmevpg1 gene. Moving forward with defining the biology of Tmevpg1, one area lacking 
experimental evidence is how Tmevpg1 localizes or tethers to the Ifng locus. As the 3D 
conformation of the Ifng locus data suggests, the Tmevpg1 gene is brought into close 
proximity of the Ifng promoter allowing for simultaneous co-expression of both Ifng and 
Tmevpg1 (Figure 5-1). In light of the work establishing a role for Tmevpg1 physical 
association with WDR5, perhaps similar to HOTTIP, Tmevpg1 may function as a 
molecular scaffold. To further assess this possibility it will be useful to employ a novel 
technique called ChIRP-seq, chromatin isolation by RNA purification followed by 
sequencing, to identify not only protein-RNA but also RNA-DNA interactions (137). With 
this approach, Tmevpg1-specific locations across the genome can be determined.  
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FIGURE 5-1. 3D conformation of the Ifng locus brings regulatory elements in close 
proximity to the promoter.  CTCF binding sites are indicated by black arrows. Relative 
transcription factor binding is representative of interactions with CNSs across the locus. 
The TMEVPG1 gene is shown in green and IFNG in red (26). Whereas the looping event 
previously excluded the TMEVPG1 lncRNA transcript, my work suggests that TMEVPG1 
could co-localize with the IFNG locus due to intrachromosomal looping.  
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In the final data chapter, I describe a pilot RNA-sequencing experiment that our lab 
has undertaken to identify additional lncRNAs that are involved in the process of Th1, Th2 
and Th17 development in human polarized PBMCs. This study identifies nearly 2,800 
individual transcripts that are expressed among the three polarization types assessed. We 
could identify nearly unique lncRNAs elevated in a Th1, Th2 or Th17-specific manner. 
Genes encoding lineage specific lncRNAs were enriched in the genome adjacent to lineage 
specific protein-coding genes with immunologic functions. Expression of transcripts 
detected from RNA-sequencing correlated strongly with RT-PCR results of assessed 
genes. However, enumerated transcripts and genomic placement among protein-coding 
genes does not implicate function. Assigning priority for future investigation will be 
difficult with this significant number of newly discovered lncRNAs; however, beginning 
with known protein regulators of transcriptional networks such as the master transcription 
factors will be an optimal place to start. Similar to TMEVPG1, we found a lncRNA 
expressed specifically in Th2 cells named GATA3-AS1 that is expressed by primary 
cultured Th2 cells offering feasibility to future experimental investigations. Utilizing a 
similar strategy that we employed to study TMEVPG1 including transcription factor 
dependence, siRNA-mediated suppression and target gene analysis will be essential to 
assign meaning to the lncRNA networks that may play critical roles in T helper cell 
differentiation. Our observations are consistent with a recent publication that identified 
greater than 1,500 individual lncRNA transcripts expressed by 42 examined subsets of 
murine T cells particular during the process of CD4+ T cell polarization (134). T-bet was 
confirmed in this study to associate with the Tmevpg1 gene supporting our findings 
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described in Chapter III (61). Moreover, in addition to Tmevpg1, T-bet was also found to 
associate with numerous lncRNA-encoding genes within differentiating T cells supporting 
a greater lncRNA regulatory network driven by master transcriptional regulators.      
To date, there is one paradigm that has been established for lncRNA regulation of 
genes by epigenetic modifications: repressive lncRNAs associate with EZH2 containing 
methylation complexes that establish and sustain H3K27me3 marks and enhancers 
associate with MLL/Set1 complexes containing WDR5 promoting H3K4me3 mark 
formation (38, 99). This paradigm seems to be quite narrow due to the extensive 
modifications of histones that are formed (e.g. acetylation, phosphorylation, sumolyation) 
and influence gene expression (9). Additionally, association between lncRNAs and 
removal of histone marks has not been demonstrated. The question of whether these 
observations are, in fact, the paradigm or whether it is a consequence of our limited 
experience remains to be determined. At present the odds are stacked disproportionately as 
fewer than 1% of lncRNA have been assigned a biological function and a smaller 
proportion of that number regulate genes at the epigenetic level. I predict that other 
associations will arise as the breadth of lncRNA function becomes more defined.  
If the paradigm for lncRNA association with histone modifying complexes outlined 
above is correct, it supports the existence of common structural motifs of lncRNA 
transcripts contributing to lncRNA functional interactions with proteins. While genomic 
sequence conservation among lncRNAs is certainly not the case, then perhaps RNA 
structural motifs dictate the limited choices for protein-lncRNA interactions (138). At 
present, structures of lncRNA are poorly defined reflecting the consensus in the RNA 
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biology community regarding our understanding of RNA structure (47, 138-140). As RNA 
is quite dynamic as a molecule, significant strides in identifying domains of protein-
lncRNA and further lncRNA-protein-DNA interactions through biochemical and structural 
methodologies will define the future of this growing field.  
 The fundamental purpose of my work translates to a broader question of the process 
of cellular lineage commitment and terminal differentiation. Cell types within 
compartmentalized biological systems arise from a common precursor; for example, cells 
of the immune system arise from a common hematopoietic progenitor (141, 142). How a 
variety of effector cell types develop and maintain terminal differentiation is an incredibly 
complex question in biology.  Cellular differentiation through stochastic niche signals 
elicits cell type-specific gene expression for example: the hematopoietic progenitors in the 
thymus begin to develop linearly into immature thymocytes expressing key surface 
molecules regulated by transcription factor networks or a naïve CD4+ T cells becomes 
activated and “commits” to an effector polarization program (141, 142). How lineage-
specific terminal differentiation is maintained is not known. In light of my observations as 
well as the work of the greater lncRNAs community, lncRNAs may be instrumental to this 
process. LncRNAs are expressed in nearly all developmental systems located nearby target 
protein-coding genes allowing for diffusible accessibility (8). Could perhaps lncRNAs 
serve to maintain gene expression patterns exhibited by lineage-committed cells, which 
may, in fact, be regulated by complex lncRNA expression networks?  
 My work supports the notion that this is at least is a feasible hypothesis:  inducible 
lncRNA gene regulatory networks that are co-expressed with and regulate expression of 
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protein-coding genes to establish lineage specification. Tmevpg1 and Ifng represent one 
example.  Induction of specific lncRNA networks from progenitor cells to effector Th1 
cells that are fully committed to their respective effector phenotype, it becomes likely that 
lncRNAs contribute to maintenance of lineage-specific gene expression, as is the case for 
Tmevpg1.  
In summary, lncRNAs function to regulate target gene transcription through a 
variety of mechanisms including recruitment or sequestration of histone-modifying 
complexes and transcription factors, nucleotide homology with mRNA or DNA and as 
precursors of smaller noncoding RNA. Moreover, these studies pose the question of how 
many other biological systems are too regulated by lncRNAs. Herein, I describe evidence 
for the lncRNA Tmevpg1 contributing to Th1 development. With certainty, future studies 
will identify additional lncRNAs contributing to all terminally differentiated cell types 
establishing as well as reinforcing all cell lineage-specific gene programs. 
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